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for contraception  and (2) shift current  users from subsidized  to
more nearly self-supporting  outlets  - without  compromising
coverage,  equity,  or quality  of care.
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Even if per-user costs are controlled or reduced,  free up scarce resources in clinical facilities and
the rising demand for family planning services  the time of limited medical personnel for the
will far outstrip governments'  and donors'  resupply of contraceptives. However, if steriliza-
financial resources in most parts of the develop-  tion is to be emphasized, a close link with
ing world. This "resource gap" lies at the heart of  existing hospital infrastructure is necessary.
donor-sponsored initiatives to involve the private
sector in family planning, but there are other  Nonclinical distribution favors commercial
equally good arguments for doing so. Govem-  systems in urban and periurban settings and
ments and donors are often unaware of how  community-based distribution systems (either
much the private sector (especially the commer-  public or private) where commercial networks
cial sector) already participates - and could  break down. Price subsidies might be considered
participate - in family planning.  in areas served by commercial systems, but
where consumers cannot afford prevailing
Foreit discusses why the private sector  commercial prices.
should be involved in planning, how the private
sector should be defined, what the experience has  Foreit discusses a wide range of experiences
been so far with private sector involvement, and  in providing both "supply" methods and clinical
what might be expected in the future.  methods, such as sterilization (including tubal
ligation). Roving sterilization camps have proved
To support family planning  in the private  effective in Nepal and Thailand, for examnple,
sector, she recommends that donors (1) expand the  where demand for the procedure was high; they
total family planning market to help satisfy existing  may have backfired in other areas, such as India.
and future unmet needs for contraception  and (2)  Mobile clinic vans have been tried in such
shift current users from subsidized to more nearly  countries as Colombia and Guatemala, but their
self-supporting  outlets  - without compromising  effectiveness and cost-efficiency have not been
coverage, equity, or quality of care.  carefully analyzed.
The kinds of private sector activities that  Among the topics Foreit covers: when to
donors should support depend in part on which  subsidize goods and services, when to introduce
contraceptive methods are to be emphasized.  new subsidized nongovernmental organization
Nonclinical systems, for example, are the most  outlets, which regulations may inhibit the
efficient way to distribute supply methods (for  expansion of private family planning efforts,
example, oral contraceptives and condoms), as  how to foster demand for private sector family
long as medical backup is available for women  planning goods and services, and how to pro-
who suffer side effects or who wish to switch to  mote the private supply of such goods and
another method. These systems of distribution  services.
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Even if per-user costs are controlled or reduced, the rising demand for family planning
services will far outstrip governments' and donors' financial  resources in most parts of the developing
world.  This much-discussed "resource gap" lies at  the heart of donor-sponsored private sector
initiatives, although there are other equally good arguments for private sector involvement in family
planning.  Governments and donors are often unaware of both the current participation and future
potential of the private sector in general, and the commercial sector in particular.
Throughout the developing world, the private sector plays a significant role in financing
and providing health care, yet reliance on private family planning outlets is often less than the use
of private sources for other kinds of health care.  This discussion of private sector approaches to
expanding family planning services will cover the following issues: (a) why the private sector should
be involved in family planning; (b) how the private sector should be defined; (c) what has been the
experience to date with private sector involvement; (d) what might be expected as a result of greater
private sector participation;  and finally (e) what measures donors should take to support private sector
family planning.
2.  Why the private sector should  be involved  in family  planning
The  reasons  for  private  sector  involvement  in  family  planning  are  simple  and
straightforward.  First, many consumers are willing and able to pay for family planning goods and
services.  Second, given a  favorable business climate, in many countries the private sector can
deliver more family planning goods and services than it currently provides.  Third, private sector
resources are needed if developing countries are to reach their contraceptive prevalence and method
mix targets.
It has been argued that family planning is a public or merit good, and therefore that
governments should take  responsibility for providing leadership and  resources to  increase both
demand and supply of services and supplies (Cochrane et al.  1990).  This argument is based on the
assumption that individual consumers are not willing or able to pay for the family planning services
that they need.  This assumption warrants closer examination.
It is probably not the case in much of Latin America that consumers are not willing to
pay for family planning.  Throughout the region, contraceptive prevalence began to rise long before
governments became actively involved in promoting family planning, the private sector now covers
large  segments of  the  market,  and-perhaps  a  more  telling  indicator of women's  interest  in
controlling their own fertility-induced  abortion, although illegal, is emerging as an important  fertility
determinant.  In Asia, early government involvement in population policy and virtual control of the
family planning market makes it difficult to determine consumer willingness to pay for contraception;
and as long as contraceptive rates remain high and governments willing to pay the costs,  private
sector involvement will be low.  Africa, and especially Sub-Saharan Africa, continues to show high
fertility and low contraceptive prevalence, although significant advances have been made in the last
decade in three countries.  Large family size ideals held by many segments of the population lend
support to the argument that demand is low; however, recent increases in abortion rates (Coeytaux
1988) indicate that women are in fact interested in regulating their fertility.
3.  Definition  of the private sector
While  the  motivations to  adopt family  planning are  varied  and  include economic,2  Pilvate Sector Approaches  to Effective Fandly Planning
psychological, and health factors, among others, the mechanisms for doing so are similar to other
hcalth behaviors and thus subject to the constraints of the overall health sector.  The user's  first
inclination may be to seek family planning from the same source as he/she obtains other health
interventions, especially preventive health care.  Specialized or vertical family planning programs
have been created when the existing health sector was thought to be inadequate  to the task of service
delivery, when potential  users were excluded  from existing health outlets, or when prevailing govern-
mental policies precluded the health sector's involvement in family planning.
In order to discuss the role of the private sector in family planning, it is important to first
delineate attributes which can distinguish the public and private sectors.  We will consider the
following  three dimensions: outlet, administration, and.financing. Each can take one of two values-
public or private.  By outlet is meant ownership of the facility.  By administration is meant whether
program management is employed by the government  or by a private entity.  Financing is considered
public if the main source of operating funds derives from the general treasury (tax revenues, loans,
official donors, etc.), and private if it derives from users, employers, or private donors.  Staffing of
service delivery personnel will not be considered as a defining criterion.  Staff may  "belong" to
either the outlet or to the administration.
These  three  dimensions yield  eight  possible configurations of  facility  ownership,
administration, and financing, as shown in Figure 1 below.
FIGURE  1
Classification of the Health Sector
ADMINISTRATION
FACILITY  FINANCING  Public  Private
Public  Public  Pure public  Privatization
Private  Forced payments  Partnership
Social security  Rental
User charges
Private  Public  Nationalization  Subsidy
Subvention
Social marketing
Private  Caretaker  Pure private
Conservator
This paper will cover the configurations listed in the right-hand column of Figure 1,
namely those administered by the private secior.  It will begin with the purely private sector, that
is, the use of privately owned and administered facilities or outlets, financed primarily by fees or
third-party payments.  This sector is influenced by government regulatory policies but generally does
not depend  on government financing  or infrastructure. Then various combinations of public financing
and use of public facilities will be discussed, including subsidies and social marketing, privatization
schemes, and public-private partnerships.
3.1.  Classification of private  sector conrigurations
The private sector is often divided into two mutually  exclusive categories, for-profit and
nonprofit,  usually  on  the  basis  of  ownership of  facilities and  program administration.  ThisDefinidlon  of the private sector  3
classification ignores modes of financing  and may obscure important distinctions  within the for-profit
category.  Just as we used the dimensions of facility, administration, and financing to define the
domain of the private sector, we  can use the dimensions of facility and financing to distinguish
various private sector configurations.
FIGURE  2
Classification  of the Private  Health  Sector
FINANCING
FACILITY  User  Employer  Donor
Retail  Commercial  Insurance  Social
outlets  marketing
Private  Commercial  Insurance  Pilot
FOR  practice  projects
PROFIT
Managed  HMO  HMO  Pilot
medical  care  projects
industrial  Employer-  Pilot
services  based  projects
NOT  Non-  NGO  Insurance  NGO
FOR  governmental
PROFIT  organizations
Historically,  donor  support  to  the  private  sector  has  been  channeled  through
nongovernmental  organizations (NGOs), while the for-profit sector has been supported primarily by
user fees  and  to  a  lesser  extent  by  third-party payments.  It  has  been  assumed, but  seldom
systematically  documented, that NGOs serve users who cannot afford commercial prices or who live
beyond the reach of the organized health sector.  The extent and potential of user and third-party
financing to support not only commercial outlets but also NGOs has until recently been overlooked
in strategic planning for  family planning programs.  The first  systematic efforts  to  use donor
subsidies to stimulate commercial sector activity were contraceptive social marketing projects.  More
recently, donor-supported  pilot projects have attempted to increase supply of family planning  among
private practitioners, managed medical plans, and industrial or employer-based health services.
4.  Private sector coverage  of the family planning  market
In  almost every  country,  private  sector  expenditures and  financing account for  a
measurable portion of the health sector,  although the contributions vary widely from country to
country and bear no systematic relationship to total health expenditures.  In Asia, Griffin (1990)
found that  private spending (excluding insurance) accounted for more than half of total spending in
7 of 13 countries reviewed.  Similarly, a review of health expenditures and revenue sources in Sub-
Saharan Africa (Vogel 1989)  found appreciable  private sector outlays, including NGOs and missions,
modern  private  outlets, and  traditional  healers.  Nongovernmental health  expenditures clearly
predominated in  10 of the  15 countries reviewed.  Latin America probably has the most well-
developed private health market, especially in the commercial subsector.  For example, private
expenditures account for  roughly half of all health spending in both Brazil and Peru (Bruns and4  Private Sector Approaches to Effective Famnly  Planning
McGreevey 1988; Zschock 1988).
Given an array of health outlets and financing mechanisms, the choice of outlet at a
given point in time will depend on such factors as the availability of the service needed and its cost,
including both absolute and relative price and user's opportunity costs such as time spent to reach
the outlet and waiting time.  Thus a woman may use a private medical group for prenatal and sick
baby care, give birth at a social security hospital, vaccinate her child at a Ministry of Health post,
and purchase simple medications at a pharmacy.  Where she would go for a contraceptive method
would  depend  on  where  family  planning services were  available,  how  much  they  cost,  the
convenience and quality of the service, etc.
The decision to seek medical attention and the outlet chosen depends on a number of
factors, including the perceived gravity of the situation, relative costs, and the perceived quality of
care.  In a  recent survey in Lima,  Peru,  36.5 percent of those individuals with an accident or
symptoms perceived to warrant medical attention did not, in fact, obtain treatment. In contrast, only
12.8 percent of pregnant women did not receive any.  prenatal care and 10.3 percent did not receive
medical attention at delivery, while 38.2 percent did not receive postpartum care for themselves (INE
1988).  Clearly,  illness and postpartum care are seen as less needing of medical attention than
prenatal care and childbirth.  A similar pattern of behavior has been noted in other countries, such
as Kenya (Mwabu 1986).
Moreover, the sources chosen for medical attention among those who do seek treatment
also vary by condition, as can be seen from Table 1.
TABLE  1
Use  of  public  and private  commercial  health  outlets:
metropolitan  Lima,  Peru
CONDITION
SECTOR  ILLNESS  PRENATAL  DELIVERY  POSTPARTUM
Public  sector  32.5%  66.8%  73.5%  44.1%
Private  commercial  27.4%  19.7%  16.1%  16.0%
No care  40.1%  13.5%  10.4%  39.9%
Source:  1984  National  Health  and Nutrition  Survey
It  is interesting  to  note  that the  use of  public  sector  facilities  is lowest  for  illness and
highest  for  prenatal and  delivery care.  Perceived quality  may be  a  factor;  medical supplies,
especially prescription drugs, tend to be in short supply at public facilities, which may encourage
potential clients to go directly to pharmacies for treatment and bypass physicians altogether (almost
one third of private zommercial use for illness is provided by pharmacies).  On the other hand,
public facilities-especially  social security hospitals-have  a reputation for adequate maternity care,
which may encourage clients to use them for prenatal and delivery care rather than resorting to
paying private providers. Furthermore, maternity care in private hospitals is priced beyond the reach
of most consumers, even those with private health insurance.Private  sector  coverage  of  the  fandly  planning  market  5
The extent  to which  family  planning  users rely on private  services  and supplies  depends
on a number  of factors,  including  total contraceptive  prevalence  and method  mix,  participation  of the
private sector in the overall health market, and existence of special-purpose  family planning
programs, principally  NGOs.  The following  table reports prevalence  and source of modem
contraceptive  methods  for countries  in Latin America, Africa, and Asia.  Ttaditional  methods,
including  all forms of periodic  abstinence,  have not been included,  as they often do not have an
identifiable  "source"  and their lower use-effectiveness  makes  them less of a programmatic  priority
than modern  methods. Thus, the figures  in the table differ  from others reported  in earlier  reviews
(for example,  Lewis  and Kenney  1988). The "other"  source  category  is not included,  and the private
sector  has been  divided  into  pharmacies  and shops,  commercial  health  providers  (private  physicians,
hospitals,  and clinics),  and NGOs. Finer distinctions  (e.g., pharmacy  sales  vs. social  marketing)  will
be discussed  later.
At first glance, it is 'lifficult  to discem  any clear-cut  trends in these  findings. Within
and across regions, countries  differ widely  in total prevalence,  method  mix, and sector coverage.
Within regions, increasing  use of pills and of female  sterilization  is correlated  with total modem
method  prevalence  The correlations  between  pill use and total prevalence  are .775 in Latin America
and the Caribbean;  .922 in Africa;  and .340 in Asia/North  Africa. The correlations  between  use of
female  sterilization  are total prevalence  .745 in Latin America  and the Caribbean;  .707 in Africa;
and .587 in Asia/North Africa.  IUD use, however, is correlated with total modem method
prevalence  in Africa (r =  .659),  but not in Latin America  (r = .094)  or in Asia/North  Africa  (r =
.278).  Unlike other modern  methods, IUDs are seldom encountered  outside  organized family
planning  programs.
The segmentation  of the family  planning  market  between  the public  and private  sectors
is influenced  by government  policies, method  mix, and health infrastructure,  as well as by total
prevalence.  Relationships  among these variables are bidirectional  and mutually reinforcing.
Regional  differences  are pronounced. As can be seen in Table 3, the nongovernmental  share of the
family  planning  market is equal  to or greater  than its share  of the health  market  in all four countries
of Latin America  for which  data are available. In Sub-Saharan  Africa,  the nongovernment  share of
the family  planning  market  is greater than its health  market share in two countries  and less than its
health market share in three countries. Finally, the nongovernment  share of the family planning
market is much smaller  than its share of the health market in all four countries  in Asia and ir one
of the two countries  in North Africa.
The importance  of  historical factors in determining  these patterns should not be
overlooked. In Latin America,  the onset of the demographic  transition  predated  organized  efforts
in population  and family  planning. In Chile,  Brazil,  and now  Bolivia,  the family  planning  movement
grew out of concern  with rising  abortion  rates  and abortion  complications.  By  the time governments
and donors  were prepared  to support  family  planning,  there was already  a well-established  demand
and a private  commercial  market  for contraceptive  goods  and services.
In Asia, governments  took  the lead  in promoting  the small-family  ideal  as a development
goal  and in providing  contraceptive  outlets. Heavy  government  involvement  in family planning  can
still be seen. Africa  is a relative  latecomer  to organized  family  plannirg. Donor-supported  activities
have  focused  on developing  national  population  policies  and program  assistance  to government  and
NGO family planning  associations. Controls on access to foreign exchange  and restrictions  on
imported  goods (including  contraceptives)  constrains  the private sector  in Africa.6  Private  Sector  Approaches  to Effective  Fandly  Planning
TABLE  2
Source  of contraception  amoncg  users  of modern  methods
OUTLETS
PREVA-  PUBLIC  PHAR-  PRIVATE
COUNTRY  METHOD  LENCE  SECTOR  MACIES  PRACT  NGOs
Latin  America  and  the  Caribbean
Bolivia  Modern  methods  12  34  9  54  1
1989  Pills  8  38  46  2
IUD  z  20  77  2
Female  steril  4  62  38  0
Brazil  odern  methods  56  28  46  23  1
1986  Pills  25  4  93  1  1
IUD  0
Female  steril  27  55  42  1
Colombia  Modern  methods  55  25  29  11  32
1990  Pills  14  18  74  1  3
IUD  12  44  21  32
Female  steril  21  23  15  60
Dominican  Modern  methods  47  42  4  44  1
Republic  Pills  9  41  17  10  3
1986  IUD  3  71  22  2
Female  steril  33  40  56  0
Ecuador  Modern  methods  36  42  6  35  17
1987  Pills  8  33  20  32  15
IUD  10  28  34  38
Female  steril  15  58  35  7
El Salvador  Modern  methods  44  78  6  4  13
1985  Pills  7  48  28  4  19
IUD  3  86  6  7
Female  steril  32  86  2  12
Guatemala  Modern  methods  19  32  7  18  40
1987  Pills  4  29  12  12  44
IUD  2  11  41  48
Female  steril  10  42  18  38
Honduras'  Modern  methods  33  19  15  10  52
1987  Pills  13  18  34  2  42
IUD  4  50  21  29
Female  steril  13  11  15  71
Mexico  Modern  methods  45  63  22  14  0
1987  Pills  10  32  63  3  1
IUD  10  77  20  0
Female  steril  19  79  20  0
Peru  Modern  methods  23  54  2  31  2
1986  Pills  6  49  32  4  2
IUD  7  58  32  4
Female  steril  6  68  29  0Private sector coverage of thefamily  planning market
Table 2, cont.
OUTLETS
PREVA-  PUBLIC  PHAR-  PRIVATE
COUNTRY  METHOD  LENCE  SECTOR  MACIES  PRACT  NGOs
Trinidad &  Modern methods  44  38  37  9  15
Tobago  Pills  14  31  53  8  7
1987  IUD  4  44  23  32
Female steril  8  67  19  12
Sub-Saharan  Africa
Botswana  Modern methods  32  94  1  4  0
1988  Pills  15  96  1  2  0
IUD  6  93  6  0
Female steril  4  91  8  0
Burundi  Modern methods  1
1987  Pills  0
IUD  0
Female steril  0
Ghana  Modern methods  5  35  23  2  19
1988  Pills  2  27  30  3  27
IUD  0
Female steril  1  81  3  3
Kenya  Modern methods  18  70  1  15  12
19?  9  Pills  5  68  1  11  18
IUD  4  75  12  12
Female steril  5  77  19  4
Liberia  Modern methods  6  31  13  5  49
1986  Pills  3  21  18  4  56
IUD  1
Female steril  1  62  8  27
Mali  Modern methods  1
1987  Pills  1
IUD  0
Female steril  0
Ondo State,  Modern methods  4  48  28  17  2
Nigeria  Pills  1  42  29  20  1
1986  IUD  1  95  5  0
Female steril  0
Senegal  Modern methods  6  47  5  38  0
1986  Pills  4  43  3  43  0
IUD  2
Female steril  0
Togo  Modern methods  3  42  32  4  9
1988  Pills  0
IUD  1
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Table  2, cont.
OUTLETS
PREVA-  PUBLIC  PHAR-  PRIVATE
COUNTRY  METHOD  LENCE  SECTOR  MACIES  PRACT  NGOs
Uganda  Modern  methods  2  49  3  10  36
1988/89  Pills  1  31  6  13  47
IUD  0
Female  steril  1  90  10  0
Zimbabwe  Modern  methods  36  53  2  2  39
1988  Pills  31  52  1  1  41
IUD  1  28  31  28
Female  steril  2  79  11  7
Asia/North  Africa
Bangladesh'  Modern  methods  24  71  18  3  5
1989  Pills  9  43  36  5  11
IUD  2  89  2  4
Female  steril  9  97  2  0
Egypt  Modern  methods  35  24  53  20  0
1988  Pills  15  10  87  0  0
IUD  16  43  54  1
Female  steril  2  73  25  0
Indonesia  Modern  methods  44  80  2  10  0
1987  Pills  16  78  2  3  0
IUD  13  89  10  0
Female  steril  3  94  6  0
Morocco  Modern  methods  21  61  9  11  1
1987  Pills  17  60  11  7  1
IUD  2  73  23  3
Female  steril  2  70  27  0
Sri  Lanka  Modern  methods  40  85  3  5  2
1987  Pills  4  66  14  11  1
IUD  2  95  4  1
Female  steril  25  95  2  1
Thailand  Modern  methods  66  82  7  7  1
1987  Pills  20  70  23  5  0
IUD  7  95  3  0
Female  steril  22  91  8  0
Tunisia  Modern  methods  40  77  14  9  0
1988  Pills  9  41  49  8  0
IUD  17  89  11  0
Female  steril  12  98  2  0
Source:  Demographic  and  Health  Surveys,  unless  noted  otherwise.
'Epidemiology  and  Family  Health  Survey.
2 Bangladesh  Contraceptive  Prevalence  Survey.Private  sector  coverage of thefamily  planning market  9
TABLE  3
Private  sector  coverage  of  family  planning
vs.  health  care  expenditures
FAMILY  PLANNXNG  HEALTH  EXPENSES
PREVALENCE  NON-GOVT  PER  NON-GOVT
SHARE  CAPITA  SHARE
Latin America/Caribbean
Brazil  12  66  50
Colombia  55  75  69.60  33
Ecuador  36  58  46.11  39
Peru  23  46  62.12  47
Africa
Botswana  32  6  36.65  44
Kenya  18  30  50
Senegal  6  53  17.73  38
Uganda  2  51  9.73  80
Zimbabwe  36  47  29.58  40
Asia/North  Africa
Bangladesh  24  29  59
Egypt  35  76  16.53  58
Indonesia  44  20  15.03  62
Morocco  21  39  23.53  55
Sri  Lanka  40  15  10.25  40
Thailand  66  18  19.56  70
Sources:  DHS;  Akin  et  al.  (1987);  Vogel  (1988);  Griffin
(1990);  Bruns  and McGreevey,  (1988).
Cochrane  et  al.  (1990) have  suggested that  private  sector  coverage  is  inversely
proportional to governmental willingness to involve itself in family planning, and that the balance
between commercial and NGO involvement is a function of level of demand.
In many countries in the early stages of demographic transition when family planning
is controversial and demand is low, the nonprofit NGOs usually assume a very large part
of the responsibility.  Where demand is high, the for-profit private sector will also be
active.  For the most part,  Latin America is an example where demand is high, the
governments regard family planning as too controversial to become actively involved,
and the private sector and NGOs provide the majority of family planning services.  . .
Africa has until recent years been characterized by low demand and low government
commitment and poor primary health care and thus, family planning has been provided
primarily  through  NGOs.  . . . Asia has shown  a very  strong  government  commitment
to reducing population growth to stimulate economic growti  and the govemment sector
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Cross et al. (1991) examined the relationship  between economic and political factors and
for-profit contraceptive market share among the 27  countries for which DHS data are available.
Urbanization, secondary school enrollment, and per capita GDP were all positively correlated with
private sector use, and use of private sector outlets was generally higher in urban areas than in rural
areas.  These results parallel those reported earlier by Kenney and Lewis (1989). Government family
planning program effort showed a curvilinear relationship with private sector use with peak private
sector market share at  approximately 52.5  on the  Laphawm-Mauldin  scale of  government effort
(maximum possible score 120); countries below this point showed a significant positive correlation
between government effort and private sector coverage (r =  .62, p  <  .01), while countries above
this  point showed a  significant negative correlation (r  =  -.71,  p  <  .05).  Furthermore,  of  13
countries with time trend data, six showed loss of private sector market share of greater than  10
percent between the two surveys, which only one country showed appreciable private sector gain.
Cross et al. conclude that while a favorable political climate can stimulate the private sector, strong
government programs have the effect of crowding out the private sector.
The contraceptive market is partially defined by the different family planning methods
themselves.  Prescription norms notwithstanding,  supply methods (pills, condoms, and spermicides)
can be sold wherever pharmaceuticals  are found, including  pharmacies, dispensaries, and small shops
and vendors' stands.  All else being equal, the private commercial sector should show a comparative
advantage in distributing supply methods.  Temporary  clinical methods (IUD, implant) require some
sort of health facility,  more highly trained personnel, minimum standards of hygiene, and some
degree of privacy for the provider and client.  They are also likely to be subjected to self-imposed
controls from within the medical community (such as requiring that only physicians can insert IUDs,
despite empirical evidence that well-trained nurses and midwives  can perform the procedure as well
as or better than physicians). Female sterilization  depends both on the existing clinical infrastructure
and on the conditions under which sterilization is performed. Even when performed on an outpatient
basis, laparoscopy or mini-laparotomy requires at least a surgical area and minimum conditions of
hygiene.  Thus, if all the surgical facilities in a given countrv are located in public hospitals, women
must of necessity use that sector if they wish to be sterilized; whereas the existence of a private
clinical infrastructure permits some degree of possible choice between public and private sectors.
Other factors  relating to specific methods can affect the shape of the market.  For
example, where access to sterilization is restricted and women cannot obtain interval sterilizations
(interval procedures are those which are performed at any time other than following a pregnancy
termination), those who want to be sterilized will resort to other avenues, such as paying a physician
to perform the procedure during an often otherwise unnecessary cesarean section delivery.  Provision
of sterilizations will follow usage patterns of hospital delivery; the greater the proportion of hospital
births attended in the public sector, the smaller the private sector coverage of female sterilization.
Easing restrictions on sterilization may increase private sector participation, especially
to the extent that public facilities are oversubscribed. Since an interval procedure is elective, women
may have difficulty scheduling an operation in a public facility if the surgical facilities are already
crowded with deliveries and life-threatening conditions.  Private organizations may take advantage
of the demand for interval sterilizations by constructing or equipping outpatient surgical facilities;
conversely, organizations  whicL  have access to surgical .icilities may aggressively promote outpatient
tubal ligations and thus increase demand.
The  effects of  government norms  and  ownership of  infrastructure can be  seen  in
coverage of female sterilization in Latin America.  In Brazil and the Andean region,  access to
sterilization has been limited to high repreduotive risk women, forcing those who do not meet the
requirements to resort to "informal" postpartum sterilization via cesarean section.  In other countries
such as Colombia, Mexico, and Guatemala, sterilization norms are less restrictive, which in principlePrivate sector coverage of the fanmly  planning market  t
should allow women greater access to interval procedures.  Data on timing of female sterilization-
-following  a cesarean section delivery, following  a vaginal delivery, or interval-are  available  for nine
countries in Latin America.  Across the region, there  is no consistent relationship between total
prevalen.  s,f female sterilization and timing of the procedure, suggesting that norms per se are not
a  significant determinant of adoption of this  method.  The proportional use  of cesarean section
procedures is negatively correlated with proportional use of interval procedures (r =  .69, p <  .05),
suggesting that norms do affect the timing of the procedure.  Finally,  private sector coverage of
sterilization shows a positive relationship with absolute  prevalence of interval sterilizations (r =  .81,
p  <  .01), supporting the hypothesis that less restrictive sterilization norms encourage or permit
greaier private sector participation.
Ownership of clinical facilitie-s  is another potential factor in private sector coverage of
sterilization,  especially under  restrictive norms which encourage inpatient, post-cesarean section
procedures.  Within Latin America, Brazil and Peru show the highest relative rates of sterilization
by cesarean section (65 percent and 51 percent, respectively, of all female sterilizations).  Hospitals
in Brazil are divided almost equally between the public and  commercial sectors; as a  result, 42
percent of the users of female sterilization were operated in commercial sector hospitals.  In Peru,
the private sector controls 25 percent of the hospital facilities, and the commercial sector accounts
for only 29 percent of tubal ligations.
Because of its relative ease of distribution, pills and other supply methods should be the
most sensitive  to market pressures of supply and demand.  In Latin America, oral contraceptives  are
well accepted, and there is a strong positive correlation between absolute pill prevalence and private
sector coverage: those countries with the highest pill prevalence also show the highest participation
of pharmacies in the pill market (r =  .791).  In contrast, pill prevalence in Sub-Saharan Africa is
much lower: with the exception of Botswana and Zimbabwe, no country shows more than 5 percent
pill prevalence. Pill prevalence in Sub-Saharan  Africa is positively correlated with government  share
of the pill market (r  =  .450) and negatively correlated with pharmacy coverage (r =  -.517).  It
could be argued that the pili  market in this region owes its existence to government efforts to
stimulate demand.  Whether government influence can continue to stimulate demand and provide
contraceptives to growing numbers of users or will act as a cap by not permitting private market
activity remains to be seen.  Asia/North Africa shows no correlation between pill prevalence and
either govermment  or pharmacy share of the pill market.
Within the private sector, the relative contributions of private practitioners, pharmacies,
and NGOs are also varied and influenced by method mix.  This can be illustrated by comparing
Brazil and Colombia, two "advanced" developing  countries characterized by high prevalence  and low
government involvement in family planning. The balance between the commercial sector and NGOs
is shifted towards NGOs in Colombia and towards the commercial sector in Brazil.  In Colombia one
NGO, Profamilia, accounts for 32 percent of all modern method users and the commercial sector for
40 percent.  In contrast, in Brazil, the entire NGO sector accounts for  1 percent of modern method
users, whereas the commercial sector accounts for 69 percent.
Part of this difference may be due to differences in method mix: pill and IUD prevalence
are  14 and 12 percent, respectively, in Colombia, compared with 25 and less than  1 percent in
Brazil.  The commercial sector is the  major supplier of pills  in both countries:  75  percent in
Colombia and 94 percent in Brazil.  NGOs accounts for 32 percent of IUD use in Colombia, while
IUD use in Brazil is an insignificant part of the contraceptive market.  Time series data from Mexico
also show the impact of method mix on market segmentation. Private sector coverage of all modern
method users decreased from 47 to 38 percent between 1982 and  1987, which coincided with a
relative decline in the use of pills (available from pharmacies) from 30 to  18 percent of modorn
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facilities) grew from 42 to 56 percent.
In summary, the private sector has demonstrated its potential  to provide family planning
goods and services, but the extent of its involvement  depends not only on its comparative advantages,
but also on government activities and regulations.  The use of male and female sterilization, IUDs,
and condoms shows strong regional variation, due at least in part to government interventions (see
Janowitz et al.  1990).  The commercial sector shows a comparative advantage in settings where it
already controls a significant portion of the total health market, in both relative and absolute terms,
and where the available or preferred contraceptive methods can be provided through its existing
infrastructure (e.g.,  pharmacies in  Brazil that can sell pills).  NGOs may enjoy a comparative
advantage where they already control a significant portion of the health sector, or where the health
sector  is  nonexistent or  unwilling to  promote  specific contraceptive methods (e.g.,  IUDs  and
sterilization in Colombia).
The following  sections will deal with specific components of the private sector, including
commercial  delivery,  NGOs,  and  various configurations of  private  administration with  public
financing and public facilities.
4.1.  Commercial  subsector
The commercial sector consists of for-profit family planning outlets whose principal
sources of financing stem from fees or private prepayment plans such as health insurance.  They
include pharmacies and shops, as well as private physicians and midwives, either in solo practice or
at clinics or hospitals.  Lewis and Kenney (1988) describe the commercial sector as follows:
The for-profit sector functions entirely outside the public sector,  relies exclusively on
market forces,  and returns on  investment.  For-profit firms invest in producing or
distributing  contraceptives and  family  planning  services  in  response  to  consumer
demand, and are dependent upon adequate financial returns for survival.  Investment in
family planning indicates that the investment is potentially profitable.  . . . Consumer
demand, pricing,  political and economic stability, and regular and reliable access to
supply inputs are key elements in determining profitability; without these, returns may
be inadequate to attract or keep private investors (p.2).
Understanding what constitutes profitability is key to understanding the incentives for
the  commercial sector to  invest in family planning, and this  in  turn  depends on the  financing
mechanism for the particular entity in question.  Outlets which depend on fees realize profits to the
extent they generate contraceptive sales and services.  Prepayment schemes realize profits not from
services generated but from services averted; family planning becomes profitable from costs saved,
to the extent that it averts the use of other more expensive services, such as maternity or pediatric
care or the treatment of abortion complications.  Adding family planning may also permit the plan
to raise its premiums or confer a  marketing advantage over other plans which do not include the
benefit.  In the latter case, family planning coverage is profitable as a loss leader if it succeeds in
generating new business for the plan.
The commercial sector is involved in all aspects of family planning delivery, from
production of contraceptive commodities  to their distribution to retail outlets, as well as the provision
of family planning services by private practitioners. As demonstrated earlier, the relative importance
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4.1.1.  Production of contraceptive commodtes
World-wide,  for-profit  firms  are  already  the  major  producers  of  contraceptive
commodities for both the public and private sectors.  Only in socialist countries is the government
the sole producer of contraceptives.  The private sector is sole producer in 31 of the 37 countries
which manufacture oral contraceptives (including the U.S.  and Europe): the government is sole
producer in three (China, Cuba, and Poland); both government  and multinational  producers are found
in two countries; and one country maintains a public-private joint venture.  Similarly, the private
sector controls production in 15 of the 20 countries which manufacture IUDs: the government is sole
producer in  five (China, Czechoslovakia, Poland, the  former  Soviet Union, and  Vietnam) and
involved in a joint venture in one.  Finally, the private sector is the only producer in 18 of the 25
countries which manufacture condoms: the government is sole producer in six (Bulgaria, China,
Czechoslovakia, Poland, the former Soviet Union, and Vietnam) and involved in a joint venture in
one (PATH 1991).
Contraceptive manufacturing is currently concentrated in the developed countries, due
in part to the importance of donated commodities.  A.I.D. provides approximately 75 percent of all
commodities donated to the developing  world; because of procurement regulations, most of these are
manufactured in the U.S.  Nevertheless, five of the 16 countries that represent 90 percent of current
contraceptive consumption  in the developing  world are judged to be completely or nearly autonomous
in terms of contraceptive production capacity relative to their current commodity requirements for
condoms, IUDs, oral contraceptives, and injectables, and several have excess capacity (PATH 1991).
However, the calculation of surplus capacity should be evaluated cautiously, especially in the case
of condoms.  For example, Brazil s classified as a surplus country.  However, prevalence estimates
do not include condoms used to prevent transmission of sexually transmitted diseases (STDs) and
HIV.  Despite a large local manufacturing capacity, A.I.D.  shipped 42 million condoms to Brazil
between 1988-1990  to meet shortfalls generated by AIDS prevention programs.
Multinational  corporations,  through  their  local  subsidiaries,  control  much  of  the
contraceptive production in the developing world, with indigenous companies playing a smaller role.
Lewis and Kenney (1988) list the major multinational manufacturers. For hormonal contraceptives,
they include Organon (Holland), Schering (Germany), and Syntex, Wyeth, and Ortho (U.S.).  IUD
manufacturers include Organon, Schering, and Finishing Enterprises (U.S.).  Condoms are produced
by Ansell (Australia), London Rubber Industries (U.K.), and Sagami Rubber Industry (Japan).
Incentives for local manufacturing by multination.ls include the possibility of sales to
the public sector, which in some countries exceed private sector outlets.  In addition, developing
country governments may encourage local production to conserve foreign exchange, by adopting
either positive (such as tax breaks) or negative incentives (import restrictions) to do so.  Finally, the
cost of shipping imported goods may exceed the start-up costs associated with local manufacture
(PATH 1990, 1991).
Constraints to local manufacture derive from the nature of the manufacturing process
itself as well  as  macroeconomic considerations of  the country context.  Production of  modern
contraceptives is not a  cottage industry.  Orals,  IUDs,  and  condoms all  require sophisticated
machinery and stringent levels of quality control.  Once the equipment is in place, on-going technical
assistance to local manufacturers is needed to supervise the production process over an extended
period of time.  In addition, the manufacture  of orals and IUDs poses potential occupational hazards
for workers (exposure to steroid-ontaminated  dust in the case of orals, and to ethylene oxide gas
for sterilizing IUDs), which adds to the need for long-term worker training and supervision.
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import the raw materials need for production (steroids for orals, high-quality latex for condoms, and
high-quality plastic and  copper  wire  for  IUDs).  If these  raw  materials are  subject to  tariffs,
production costs will rise, and any snags in the import process (for example, changes in regulations
concerning foreign exchange) will reverberate throughout the manufacturing process.  In this sense,
contraceptive manufacturing is subject to the same constraints as any other high-technology industry.
Other deterrents to foreign investment include government restrictions on repatriation of earnings,
price controls, uncontrolled inflation, and risk of the government creating a  subsidized competing
factor or purchasing from other sources.  Certain contraceptives, like other ethical products, may
require product approval from the local country's Food and Drug Administration  equivalent, an often
lengthy and expensive proposition.
4.1.2.  Distribution  and marketing  of contraceptive  goods  and services
The use of contraception is a discretionary behavior under the user's  direct control;
successful marketing of contraceptive goods and services requires both creation and maintenance of
demand and  supply.  Historically, the commercial sector has done little in the way of creating
demand for fertility regulation in general or specific contraceptive methods or brands in particular.
An exception to this rule are contraceptive social marketing (CSM) projects which use donor- or
government-subsidized marketing techniques to  raise awareness of family planning and specific
brands and outlets.  CSM will be discussed separately below.
Family planning advertising may take one of two approaches.  The first,  "generic,"
approach seeks to sensitize the audience to the issue of fertility regulation or to provide information
on a wide range of contraceptive methods.  The messages in this form of advertising tend to be
general,  often promoting such concepts as  "responsible parenthood."  The second,  "selective"
approach resembles commercial, consumer products advertising campaigns, in which specific brands
of contraceptives and outlets are promoted.
Generic advertising may increase contraceptive prevalence where use is low.  Bertrand
et al. (1982) reported higher correlations between exposure to family planning messages and family
planning use in areas with relatively lower contraceptive prevalence, than in areas of relatively higher
prevalence.  However, it is difficult to interest commercial suppliers of contraceptive methods to
invest in generic campaigns because returns will accrue to their competitors as well.  In addition,
many of the suppliers who are able to afford advertising are located in areas where contraceptive
prevalence is already advanced, and will therefore stand to gain less from generic advertising.
Where contraceptive prevalence is already high, generic messages may be unnecessary.
Some researchers have argued that advertising in such areas should be more selective and focus on
promoting underutilized methods or underutilized sources (see Foreit et al. 1989).  Outside of CSM
activities, selective advertising directly to consumers has not been widely used.  Most countries
restrict brand-name advertising of all ethical products, including contraceptives.  Over-the-counter
methods, such as condoms, may be subject to self-imposed  advertising censorship from manufacturers
and distributors fearing social backlash, and point of purchase promotion may be  restricted for
similar reasons.  (It is interesting that in the U.S.,  mass advertising and promotion of condoms did
not begin until well into the AIDS epidemic).  Few suppliers have invested in systematic market
research to study consumer preferences and potential impact of advertising.
Once demand has been created, successful marketing  of contraceptives  requires a reliable
network of outlets.  Supply methods depend primarily on  retail outlets-pharmacies,  shops, etc.
While  physicians and  midwives may  play a  role in the  initial prescription of  pills and  barrier
methods, most users will go to retail outlets for resupply.  In the 1987 Mexico DHS, current family
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had gone for their most recent supply. Fifteen  percent of pill users reported  receiving  their first
cycle from a private physician,  but only 2 percent  depended  on private physicians  for their most
recent  supply  (some  of these  may  have  been  women  who  had not  yet sought  resupply). Furthermore,
many  users of oral contraceptives  and barrier methods  never  receive  a medical  prescription. Again
from Mexico, 46 percent  of pill users purchased  their first cycle at a pharmacy;  the number  who
relied on pharmacies  for their most  recent  supply  increased  to 63 percent,  capturing  most  of the users
who had begun with physicians.
Pharmaceutical  firms  rely on detailers  to market  to physicians  and pharmacists.  Detailer
promotion  includes  not only  the detailer's  direct  expenses  but the production  of promotional  material
and often free samples  of the company's  product line.  The cost of detailing  and sampling  was
reported  to account  for 50 percent  of the retail price of oral contraceptives  in Colombia,  Iran, and
the  Philippines  in  1971  (Arthur  D.  Little  1972,  cited  in  Lewis  and  Kenney  1988).  One
pharmaceutical company, Schering Ag, has a corporate policy of not promoting brands for more than
three years following product launch, on the grounds that after this time the product will either have
achieved market viability or is not worth the effort.
Retail sales are influenced by desire to control fertility, reliability of supply, purchasing
power of potential  users, and competing prices from the subsidized government and/or NGO sector.
The primary financing source for retail sales is the consumer, as most insurance and medical plans
do  not include medications for outpatients.  At this level of financing, issues of price and price
elasticity of demand are critical.
In an analysis of commercial sales statistics for oral contraceptives in the Dominican
Republic in 1982-87, Stover (1987) reported a price elasticity of -1.5 percent.  For every I percent
of price difference between competing brands, the lower-priced brand increased unit sales by  1.5
percent.  The impact of price  changes is probably even more pronounced at the extremes of the
distribution, when, for example, free commodities are introduced or prices are abruptly increased.
Donated commodities have had  destabilizing effects on  commercial markets.  The
introduction  of free government  services in Kenya and Nigeria was associated with drastic reductions
in the private market; one firm in Nigeria closed down its subsidiary altogether (Lewis and Kenney
1988).  Four years after the initiation of a community-based  distribution (CBD) program in Piauf
State, Brazil, pill prevalence had not increased; the net effect was to replace the commercial sector
share with free, donated supplies.  Finally, a recently completed retail audit in Guatemala found that
donated commodities  "leaked" from the Ministry of Health and from neighboring countries accounted
for  14 percent of the commercial market in condoms (The Futures Group 1991).
Price elasticity studies seldom employ abrupt price increases for fear of disrupting the
market.  As part of its economic austerity program, the government of Peru decontrolled prices in
August 1990.  Overnight, the pharmacy price of the most popular oral contraceptive, Microgynon,
tripled, from US$.50 to US$1.50.  Three months earlier, Microgyion had been introduced into two
CBD programs on a trial basis at prevailing pharmacy prices.  Prior to the pri e increase, distributors
were selling almost as much Microgynon to new clients as the donated CBD brand, Lo-Femenol,
which sold for US$. 10.  After the price increase, Microgynon sales dropped nearly to zero and had
not recovered 6 months later.
How  clinical contraceptive  methods are  marketed  depends  on  the  availability  of
infrastructure, including  trained providers and clinical facilities.  Physicians tend to be the primary
commercial providers of IUDs and sterilization; although many countries permit trained midwives
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There  are  few  hard  data on  the  prices  charged by  private physicians for  clinical
contraceptive methods, but evidence suggests that the prices may be quite high and unaffordable to
many users.  In some countries, IUDs are  not widely available to  the general public.  Private
physicians obtain IULDs  as contraband or through "leakage" from government or subsidized sources,
and command high prices to provide them to their patients.  Similarly, health norms or medical codes
may restrict or prohibit sterilization on demand.  Women in Brazil, Ecuador, Peru, and Bolivia have
learned that they can pay an obstetrician on the side for an 'informal sterilization," which often takes
the form of a cesarean section delivery accompanied by an unreported tubal ligation.
In  recent  years,  donors  have attempted to  increase commercial  sector delivery  of
contraceptive goods and services to users through a combination of reducing barriers to commercial
production and delivery and increasing incentives  through contraceptive social marketing and efforts
aimed at employer-subsidized health and welfare benefits.
4.1.3.  Employer-subsidized  heaith plans
Industrialization and incorporation of larger numbers of workers into the formal labor
force coupled with growing dissatisfaction on the parts of both labor and management with publicly
managed health care has led to the growth of employer-subsidized  health plans in various parts of
the developing world.  These schemes may take the form of indemnity-type health insurance, which
provides cost reimbursement to hospitals and fee-for-service  to physicians, or managed prepaid care
provided by an organized medical group.  Both are based on the concepts of group financing and
pooled rist;; in the former case, the insurance carrier  assumes the financial risk and services are
provided by third parties, whereas in the latter case the same entity both assumes the financial risk
and provides the services.  In some cases, the company maintains its own facility for employees and
dependents.
Managed prepaid  care requires  a  large  enough catchment group  of  employers and
employees to  whom  the  concept can  be  marketed  and  an  adequate  pool  of  unemployed or
underemployed health care providers interested in belonging to this kind of group practice (Group
Health Association of America 1985).  As a result, these schemes are basically confined to urban,
industrialized  areas.  Other organized community  structures such as production cooperatives may also
be able to afford prepaid plans.
Within the developing world, private prepaid medical coverage is pretty much limited
to Latin America.  Health insurance is also found in Asia, but ihe largest plans (China, Korea, the
Philippines) are financed by obligatory payroll taxes and thus should not be considered part of the
private sector.  Sri Lanka, Indonesia, and Thailand have small private insurance industries (Griffin
1990). Prepaid care is virtually unavailable in Africa, save for plans in South Africa and a growing
insurance industry in Zimbabwe.
An in-depth assessment of managed prepaid medical plans in Latin America and the
Caribbean was conducted in 1985 (Group Health Association of America 1985).  Case studies were
included for  most of the countries in South America, but a  uniform reporting scheme was not
developed.  In Bolivia, 11 health cooperatives, three insurance companies, and two HMOs were
identified, covering approximately 1 percent of the population. In Brazil, 156 HMOs were identified
covering 8  percent of the  population, as well  as 76  physician cooperatives and  several health
insurance companies.  In Colombia, three commercial HMOs were found, covering some 12,500
beneficiaries; a  small  insurance industry exists,  but  no  figures were  given.  Ecuador  had  an
unspecified number of cooperatives, six health insurance companies, and one prepaid health plan (the
last with 20,000 beneficiaries).  In Paraguay, 25 HlMOs  serving the upper and middle classes were
found.  FinaUy, in Peru,  13 percent of the population was covered by cooperatives and another 6Private sector coverage of the  fandly plannWng  market  17
percent by health insurance and prepaid plans.
Formal  labor  force  participation and  higher  income are  typically  associated with
increased contraceptive use and lower fertility.  Recent recruits to the formal labor force, however,
face a double bind.  While their new status motivates them to control their fertility, many do not
have the purchasing power to seek medical care outside their prepaid plan.  Thus, if the plan does
not include family planning, they will either do without or seek out public or subsidized NGO
sources.  In a  survey of all  major Peruvian health insurance companies in  1990, none reported
covering either prenatal care or family planning, although hospital delivery was included (Foreit
1990); likewise 17 of 28 Brazilian HMOs responding to a  1986 survey reported that they did not
offer family planning, but the industry average was even lower (Foreit  1987).  With the exception
of pioneering efforts in Asia, most notably India, few own-services programs include family planning
as a preventive health benefit.
Company-sponsored family planning programs in India date back to  the  1930s and
include TVS-Lucas (1938), Tata Iron and Steel Company (1950), Alembic Chemicals (1956), and
Hindustan Spinning and Weaving Mills, Gujarat Refinery, Godrej & Boyce, and the Tea Plantations
(early 1960s). By 1972, 132 plantations  and 146 industries were providing family planning (Rinehart
et al.  1987).  Family planning is offered in the Philippines by the Hawaiian-Philippine Company
(1970) and Philacor (1975).  By law, all companies in the Philippines that are legally required to
provide clinics or infirmaries are required to offer family planning, but not all  comply.  These
programs not only provide family planning services, but also attempt to stimulate demand for fertility
control through a series of incentives for adopting family planning (cash payments for sterilization,
etc.) and  disincentives for  large families (limiting maternity leave and  benefits for  higher-order
children).  Other  employer-sponsored motivational and  service  delivery  programs  have  been
implemented at Jamaican  sugar and bauxite companies, coffee growers  in Colombia, the P.  T.
Imbritex textile factory in East Java, Indonesia, and Pertamina Oil Enterprises (Lewis and Kenney
1988).
It appears that these programs have attracted family planning acceptors.  A survey of
married female workers and wives of male workers at Tata Iron and Steel Company found 84 percent
- contraceptive prevalence among  women resident in Jamshedpur, where  the company is located
(Wickstrom et al. 1988), half of which was due to sterilization.  Although source of method was not
asked, it was assumed that most users were served by the Family Welfare clinics maintained by the
company; in addition,  the  company supplemented the government cash  incentive for  accepting
sterilization.
Labor unions have also been involved in promoting family planning as an employee
benefit, in India, Turkey, and  Sri Lanka.  The International Labor Office, a  U.N.  organization,
subsidizes 70 projects in 35 countries (Rinehart et al.  1983), often in collaboration with UNFPA or
international NGOs.  Recently, A.I.D.  has begun to underwrite organized efforts to enlist employer
support for family planning through two world-wide assistance projects, Technical Information on
Population for the Private Sector (TIPPS, 1985-91) and the Enterprise Program (1985-91).  The
A.I.D.-funded  OPTIONS projects  have  addressed  policy constraints  to  greater  private  sector
participation in family planning, and a follow-on to the Enterprise Program (PROFIT) is scheduled
to begin in 1991.
A central feature of the A.I.D. employer-based initiatives is the financial argument that
the costs to the employer of providing family planning to employees and dependents can be more
than offset by  savings arising from averting maternity-related service costs.  Potential costs and
benefits are projected by assessing current levels of fertility and contraceptive prevalence, demand
for employer-subsidized  family planning, and the costs of providing family planning.  Pregnancies,18  Private Sector Approaches to Effective Family Planning
births, and abortions averted as a result of higher contraceptive prevalence are then projected, along
with their associated cost savings to the employer or health plan.  The principle criteria used to select
study sites were that the company already provided maternity-related benefits and could therefore
achieve cost savings from fertility reduction; and that it had sufficient  resources to absorb the start-up
costs of family planning services.
During its five years, the TIPPS project conducted business analyses in Latin America
(Brazil, Honduras, Mexico, Peru), Africa (Nigeria, Zaire, Zimbabwe), and Asia (India, Indonesia),
covering  private  employers,  insurance carriers,  and  health  maintenance organizations.  The
Enterprise project conducted fewer and less detailed cost-benefit analyses and  focused more on
providing operational subsidies and technical assistance directly to employers and family planning
service providers.  Employment-based subprojects were carried out in Latin America (Ecuador,
Mexico), Africa (Liberia, Nigeria, Uganda, Zimbabwe), and Asia (Indonesia, Nepal, Philippines).
Subprojects which did not involve direct subsidies to employers are discussed below.  Subprojects
which included direct subsidies are discussed in a later section.
A cost-benefit  analysis performed for the Commercial and Industrial Medical Aid Society
of Zimbabwe (CIMAS) found that CIMAS beneficiaries had half the national fertility rate and much
higher contraceptive prevalence than the country at large (TIPPS 1988). Consequently, although the
cost per beneficiary sreved would be modest, family planning program costs would exceed expected
benefits.  Nevertheless, the  company decided to add  family planning coverage without raising
premiums, as a way of generating goodwill among its clientele and within the government.  The
company now  reimburses family planning services provided by the  Zimbabwe National Family
Planning Council (at higher prices than charged to the general public), thus providing a significant
new revenue source for that organization.
Several other private companies have initiated more modest family planning efforts.  In
Mexico, the Gigante department store chain hired and trained a physician for the clinic at its main
store and distributes donated commodities.  In Honduras, several manufacturing firms have hired
physicians to provide family planning services and purchase commodities from the IPPF affiliate at
lower than commercial market prices.  TIPPS estimates that over the five years of the project, 12
private companies in six countries invested a  total of US$213,000 in family planning for  their
beneficiaries.  Data on acceptance and source substitution (i.e., how many program users previously
used subsidized or commercial sources) are not available.
Not every company approached adopted family planning.  For example, a large textile
company in Zaire,  UTEX Africa,  paid so few nonsalary benefits that although there was a clear
demand for family planning among employees and dependents, there was no financial advantage to
the company of preventing unwanted births.  In Peru,  a cost-benefit analysis performed for the
parastatal electric company, ElectroLima, found that company-subsidized family planning could
achieve a positive cash flow in the second year and recover its initial investment in the third year.
However, as a state-run monopoly, the company could cover any short-fall by raising rates charged
to consumers and thus had few incentives  to control costs.
Not every company approached adopted family planning.  For example, a large textile
company in Zaire,  UTEX Africa,  paid so few nonsalary benefits that although there was a clear
demand for family planning among employees and dependents, there was no financial advantage to
the company of preventing unwanted births.  In Peru,  a cost-benefit analysis performed for the
parastatal electric company, ElectroLima, found that company-subsidized family planning could
achieve a positive cash flow in the second year and recover its initial investment in the third year.
However, as a state-run monopoly, the company could cover any shortfall by raising rates charged
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BOX: A TIPPS Project in Peru
The TIPPS project conducted a  study of the potential costs  and benefits of
providing family planning to employees and spouses at Milpo Mining Company, located in
the interior of Peru.  The study found 35 percent  contraceptive prevalence among married
women and a  general marital fertility rate of 221 births per  1000 married women.  The
company paid only US$50 per birth in maternity care, but deferred benefits for medical  care,
housing, and schooling averaged over US$4,000 per child.  It was estimated that providing
family planning could raise contraceptive prevalence to 72 percent and improve method mix.
Achieving this target would produce a 74 percent fertility decline by the fifth year of the
program, for annual savings of $11,000 in immediate costs averted plus future costs averted.
Program costs would total about $14,000 in the first year and about $8,000 thereafter.  The
program would generate  a  positive cash flow in  the  third  year  and  recover  its initial
investment in the sixth year.
A unique feature of the Milpo study was the addition of a child survival module.
It  was fount" that  the  company could  achieve significant  savings  in  expenditures for
pharmaceuticals by  instituting well-baby care  and appropriate treatment of diarrhea  and
respirr  tory infection among children under age five.
As  a  result  of the  study, Milpo  initiated integrated  family planning/MCH
services in 1988.  All costs have been paid by the company.  Milpo hired an additional
physician and  nurse  educator  and  contracted  with  two  local  NOOs for  training  and
supervision.  TIPPS brokered the original training and supervision contracts and provided
occasional technical assistance in program coordination.  In the first 20 months, vaccination
coverage among children under age five rose from 5 percent to 75 percent, and almost all
children under age one were enrolled in growth monitoring.  Standardized diagnostic and
treatment protocols for acute diarrheal and respiratory infection were implemented.  The
annual wholesale value of savings in pharmaceuticals  was estimated at US$ 5,000 (Foreit et
al. 1991a).
In less than two years, contraceptive prevalence rose from 34 to 48 percent, and
use of modern methods more than doubled. Thirty-one percent of the wives of reproductive
age accepted  IUDs  in  1989, accounting for  11 percent  of  all  IUD  acceptance in the
Lima/east health region (Foreit et al.  1991b).  Fertility rates did not decline in the first
years, but pregnancy rates appeared to be declining.  (Initiating family planning should have
no  impact on  fertility during the first  year of  operations, since the  services would not
interrupt pregnancies conceived before the program began).
The Milpo model was promoted among other mining companies in the area.
Top management and medical staff from Milpo met with their counterparts from five mines
to  describe  their  experiences  with  the  new  services.  Two  mines  added  the  family
planning/MCH  services  with  existing  medical  staff  and  contracted  for  training  and
supervision.  Two other mines expressed interest in adding the services as soon as their
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4.2.  Nongovernmental  organizations
Nongovernmental organizations (NUOs) form the  second component of the  private
sector.  They have been described as a "residual" category, neither governmental nor for-profit.  For
the purpose of the present discussion, we will exclude international  NGOs, whose primary functions
are to  lobby for wider  support for  population and  family planning and to channel funding and
technical assistance to national and local groups.
Even restricting the category to national and local family planning service providers,
NGOs defy  easy classification.  They  vary  in organizational  structure,  location and  scope  of
coverage, funding sources, and services they provide.  For example, Brown and Korten (1989) define
three  organizational styles: market-oriented public services contractors,  values-driven voluntary
organizations, and member-accountable  people's organizations. Voluntary organizations "depend on
energy  and  resources  given freely  by  their  members and  supporters,  because they  believe  in
organizational missions, not because of political imperatives or economic incentives.  "  Public service
contractors,  on the other hand, are nonprofit businesses which sell "services to governments or
private donors, much as firms in the U.S. that accept contracts from government to provide a range
of municipal services from garbage collection to health delivery."
NGOs differ in geographic coverage.  Some maintain only a single installation,  whereas
others operate a network of delivery sites and outreach workers.  Institutional affiliations vary by
organization and across countries.  Some NGOs belong to international associations such as the
International Planned Parenthood Federation (IPPF); CARE, or World Neighbors.  Some belong to
national organizations, and many maintain no affiliations at all.
While the stereotypical NGO is a small-scale organization working directly in aud with
low-income communities, the economic reality for the sector is often quite different.  International
NGOs channel approximately one-third of official population assistance to the developing world
(UNFPA 1989).  Donor assistance to and through NGOs is roughly inversely proportional to host
government involvement in  family planning: in  1986-88, NGOs channeled 50  percent of total
population assistance to Latin America, 45 percent to Africa, 35 percent to the Middle East, and less
than 30 percent to Asia and the Pacific (Nassim 1991). Nevertheless, most NGOs have some degree
of local financing, and many smaller groups rely heavily on volunteer labor and donations from the
people they serve.
Many NGOs which promote and/or provide family planning  also provide other services,
and family planning is not always their primary activity.  Some were founded to provide family
planning and subsequently added other services, and some were founded for other purposes and later
incorporated family planning.  Family planning may be offered in the context of primary health or
total health care, or as an adjunct to community development activities.
Any single typology obscures the multidimensional nature of the sector.  As NGOs
evolve and diversify, distinctions among the various subgroups blur.  Consequently, it is impossible
to estimate the total number of NGOs which provide family planning.  IPPF includes 140 national
affiliates, one per member country, most of which maintain networks of service outlets.  Because
of their large and stable international funding base, IPPF  affiliates tend to be the largest private
family planning associations in their respective countries.  However, in sheer numbers, they are
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100 local organizations which operate in more than 350 locations, while Brazil registers more than
150 family planning NGOs, 170 women's NGOs, and 400 environmental groups (Martine 1990).
4.2.1.  Comparative advantages of the NGO sector
Nongovernmental organizations were the pioneers of the population movement, leading
the way in advocacy and service provision long before most governments and international agencies
became involved (Nassim 1991). Their strength is generally seen as deriving from their linkls  to, or
presence in local communities.  Donors view them as potential intermediaries between govermments
and  beneficiaries.  Many  NGOs,  whether or  not they  participate directly in  officially funded
programs, assert the importance of their community perspective in policy formation and program
development (Garilao 1987; Korten 1987).
Concern at stagnant levels of development aid is another factor in donor interest in
NGOs.  NGOs are viewed as increasing or maximizing development resources at several levels.
First, they are thought to possess the potential to mobilize local resources from the people they serve,
or  to stimulate self-help activities.  Second, they  are thought to  utilize development aid  more
efficiently than governments, by operating with lower administrative overheads, or to provide more
cost-effective services, or to use lower-cost technologies (USAID 1986). Third, many NOOs obtain
at  least a  proportion of their funding from individual and  corporate donations, thus augmenting
official development sources (Nassim 1991).
Whiie the economic reasons for assisting NGOs are attractive, others argue that the most
important developmental roles of NGOs are organizational and political rather than financial and
economic.  "The organizational capacity that comes to life through NGOs and becomes engaged in
development action represents its fundamental strategic resource and crucial contribution.  While
important, financial resources in themselves are not everything.  Often they are quite a secondary
factor in triggering genuine development" (Cernea 1988). Some observers counsel caution in donor
funding of NGOs, in order not to overwhelm their capacity to absorb and utilize resources or to
subject them to the administrative and program control that external funding usually entails.  "To do
so is something akin to killing the goose that laid the golden eggs.  It is likely to destroy the ability
of the V[oluntary] O[rganization] to generate the special resource-voluntary  social energy-that  is
the object of the planner/donor's attention" (Brown and Korten 1989).
4.2.2.  Accountability and sustainability of NGOs
Brown and Korten (1989) consider sustainability  and accountability  to be critical features
of the voluntary sector-sustainability  to the degree that activities satisfy their members' values and
expectations, and accountability in the sense that they respond to the needs of their beneficiaries.
NGOs are seen as fostering a supportive environment for family planning and serving individuals in
need of contraception who cannot afford commercial prices.  However, demand among the target
population is seldom measured, and supply is assured by  the donor community which furnishes
financial and commodity support.  The assumptions regarding the comparative advantage of NGOs-
low costs, administrative flexibility, accountability to local audiences, etc.-are  virtually untested.
Despite their contextual and organizational differences, in terms of their family planning
activities, there is little to distinguish one nonprofit from another.  This may reflect as much their
dependence on  the same group of donors  as to  commonalities in  family planning needs across
countries and regions.  Almost all NGOs see demand creation as central to their mission.  However,U  - u 
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little is known about the informational deficits of their constituency, and even less about the return
from IEC activities.
Most NGOs offer more  or  less the same products  (temporary, principally female,
contraceptive methods), all recruit from the same target population (women of reproductive age who
are unable or unwilling to pay commercial prices for family planning services), most do not charge
more than token payments for services and supplies, few apply client fees to program operations, and
most are  nearly totally  underwritten by  international donors.  Sheltered from  the  need to  be
financially self-supporting, even to the extent of purchasing commodities, family planning NGOs
have not had to deal with market forces.  Indeed, it may even be said that many compete not for
market share or profits or even users, but for increasingly scarce donor funds.
The Honduran IPPF affiliate compensated for a 19 percent decline in its CBD cover2ge,
which had been caused by a 192 percent increase in its CSM program, by increasing the number of
urban CBD distributors by 24 percent (Janowitz et al.  1991).  A competitive market player would
have reduced the number of urban CBD outlets, especially since the CSM network was demonstrably
cheaper to operate.  One might speculate that the agency was trying to bolster CBD performance for
fear of losing some of its donor subsidy.
Management capabilities are a widely recognized deficit of the sector; NGOs lack access
to assistance in developing appropriate management systems and skills, and donors resist funding
staff development expenses (Brown and  Korten  1989).  The results of an  institutional analysis
recently performed for six Peruvian family planning  NGOs (USAID/Peru 1989)  reveal organizational
weaknesses that are probably typical of much of the sector.  The NGOs tended to manage their
internal affairs to satisfy donors' requirements rather than institutional  needs; the larger the number
of individual donors, the more fragmented their management procedures.  Most had logistics and
financial management systems in place, but compliance was spotty at best and did not measure up
to usual auditing standards.  None had implemented any cost analysis system, and their revenue
generation schemes were rudimentary at  best.  The high level of dependency on outside donors
presented a significant obstacle to achieving sustainability.  As a consequence of this dependency,
the NGOs surveyed shared the following management  problems, which affect both their sustainability
and their accountability to their beneficiaries:
*  self-centered rather than market-centered values;
i  dependence on donor agencies for leadership;
. lack of a market strategy; and
*.  tendency  to  disperse  already  scarce  resources  to  cover  new  zones,  instead  of
consolidating and strengthening their existing geographic coverage.
NGOs are often singled out for donor support on the grounds that they are cheaper and
more efficient to  operate than the public sector.  To test these hypotheses, fixed costs and cost
distributions were calculated for clinics and rotating medical posts.  The analyses suggested that
operating at full capacity, the NGOs in the sample would in fact be appreciably cheaper than the
public sector (the most expensive fixed cost for an IUD insertion was US$4 vs. approximately US$12
under Social Security).  However,  administrative costs accounted for an average of 35 percent of
fixed costs; this is the weighted mean, the range being 16-65 percent.
Finally,  facility utilization and  maximum potential cost recovery were  assessed for
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TABLE 4
Productivity and cost recovery among five selected Peruvian NGOs
(in  percentages)
AGENCY
A  B  C  D  E
CATEGORY  (Lima)  (Lima)  (Lima)
CENTRAL  CLINIC
Capacity  utilization  76  54  63  66  32
Cost recovery  42  48  9  84  6
MEDICAL  POSTS
Capacity  utilization  99  78  57  52  35
Cost recovery  3  7  3  4  6
NGOs are listed in order of installed  capacity. The  first-listed  and largest agency is the  Peruvian IPPF
affiliate.  As can be seen, none of the clinics were operating at full capacity (defined as 85 percent
utilization  of space and staff), and only two agencies  warranted expansion  of their rotating medical  posts
based on current utilization. None of the rotating posts could be expected to recover more than 7 percent
of its costs.  It is clear that at the time of the study, none of the NGOs was remotely close to self-
sufficiency  and that raising  productivity  without  simultaneously  raising  prices and/or lowering  costs  would
have little impact on cost recovery.  The near-total operating  subsidies  were justified on the grounds of
equity, although the degree to which services were targeted exclusively to the poor could also be
questioned.
NGOs see their role as serving clients  who are unable to pay commercial  prices for family
planning. The ability of clients  to pay for goods and services received  is a great unknown,  due to the lack
of information  about client income and purchasing  patterns.  None of the NGOs studied  collected these
data, but information  was available  for two proxy variables-education and place of residence.
Client education  and residence  data were collected  for the three programs in Lima.  For the
IPPF affiliate, client records showed  that 87 percent  of the clinic  clients  and 59 percent of the rotating post
clients  had a secondary  education  or higher, which  would  suggest that  they could afford to pay at least part
of the cost of the services they received.  In ternis of residence, 85 percent of the clinic clients and 27
percent of the post clients did not live in marginal  urban areas ('pueblos jovenes").  Combining  the two
variables, 79 percent of the clinic clients  and 19 percent of the post clients  both had at least a secondary
education  and did not live in rarginal  areas and thus probably did not need the near-total subsidy they
received  from the program. The other two NGOs  also  served  many clients  whose educational  levals  and/or
place of residence  suggested that thew  could afford to pay more than they were being charged, although
their incomes  were probably lower than the clients served by the IPPF affiliate.
These findings were corroborated by results of a survey conducted in two of the NGOs
(INANDEP, no date).  Clients were asked where they sent their children to school: 40 percent of the
clients  of the IPPF affiliate  with school-age  children  used private  schools, as did 15 percent of the clients
of the other NGO.  Although  private  school tuition in Peru is relatively  low, nevertheless,  a family  that
can afford private tuition should still be able to pay for a larger portion  of family  planning  services than
was being charged by the NGOs.  (A third, self-supporting,  NGO was included in the survey; on all
indicators  its clients showed lower income levels than the clients served by the heavily subsidized IPPF24  Private Sector Approaches to Effective  Family Planning
affiliate.)
The A.I.D.-funded TIPPS and  Enterprise projects worked with  selected NOOs in all
geographic  regions  to assist  them  to market  family  planning  services  to  employers  and insurance  companies
and to broaden  their funding  bases. However,  donor policies,  or NGO perceptions  of those policies,  were
frequently in direct conflict  with these efforts.  Most of the NGOs contacted were oriented totally to
providing  subsidized  services, and their donors  were often  uninterested  in or opposed  to encouraging  them
to developing  marketing  capabilities. The TIPPS project  concluded  that donors' reliance on user volume
(as  measured by  couple-years of protection) as the  principal, if  not exclusive, indicator of  NGO
performance  has made the NOOs fearful of losing acceptors  by charging  for services and consequently
reduced  their motivation  to recover  costs or generate  income (JSA Healthcare  Corporation 1991).
4.2.3.  Evaluating  the  impact of NGOs
Given the diversity  of settings and program objectives, it is difficult to define appropriate
imnpact  indicators  for the sector, much less collect the appropriate  data.  Furthermore,  care must be taken
to  distinguish between NGO contributions  in  the past and their current contributions to increasing
contraceptive  prevalence  and improving  method  mix.
As was shown  earlier in Table 2, within  every geographic  region, there is wide variability  in
the proportion  of modern  method  users who obtain  their methods  from NGOs.  In Latin America, NGO
coverage  ranges  from less than 1 percent to 52 percent of modern  method  users; in Sub-Saharan  Africa,
from less than 1 percent to 49 percent; and in Asia/North  Africa from less than 1 percent to 5 percent.
There is no clear relationship  between  NGO  coverage  and either total prevalence  or method  mix.  In some
high-prevalence  countries  such as Brazil, it may  even be the case that  eliminating  NGOs would  do nothing
to contraceptive  use.  Lewis  and Kenney  (1988) suggest  that 'although NGOs are and should be a fixture
of family  planning  provision, they . ..  cannot take on the entire supply burden  anticipated  for the coming
decades."
Some argue that the NGO sector should  be evaluated  on its advocacy  efforts  to change  public
policy  and to create popular  demanid  for family  planning  methods  rather than on its contraceptive  market
share.  While these are unquestionably  valid activities,  especially early in a  country's demographic
transition,  there is no consensus  on output indicators  or proof of causality. In Zimbabwe,  the government
has taken over the Farnily Planning Association,  which now operates as a parastatal organization.  In
Brazil, despite more than 25 years of NGO activities,  family  planning  is still a highly polemic topic and
the Ministry of Health-which lists family  planning  as an integral  component  of its maternal  and child
health program-does not include contraceptives  in its basic medications  list.  Similarly,  it is difficult to
summarize  the impact of NGO promotional  efforts on demand  for family planning  in general, although
there is clear evidence that specific informational  campaigns  have increased the demand for specific
contraceptive  methods.
4.3.  Innovative approaches combining private admninistration  with public financing and/or use of
public facilities
4.3.1.  Contracepwve social marw*edg (CSAM)
Contraceptive  social  marketing  (CSM)  uses  commercial  techniques  and retail  outlets  to market
low-cost  contraceptives  to low-income  consumers. Donor subsidies  are provided for product promotion
(to stimulate consumer  demand), and donated  or subsidized  commodities  are often provided as well (to
stimulate  supply). CSM is best suited for urban and periurban  areas  where commercial  infgastructures  are
most developed,  and for products  that do not require clinical  service, such as orals, condoms,  and vaginal
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Programs subsidizing  delivery of contraceptives  through commercial  distribution  channels
began in the early 1960s. Early  projects  were designed  to complement  existing  public  and private  delivery
systems  and concentrated  on expanding  distribution  networks  and improving  commodity  logistics  systems.
They did not incorporate market planning and financial  analysis and were not designed to  become
financially  independent  or to reduce recurrent  costs.
In 1981, A.I.D.  implemented the first world-wide CSM technical assistance effort, the
International  Contraceptive  Social  Marketing  Program  (ICSMP). By 1984, there were 13 major  on-going
CSM  projects  in Asia and Latin America:  India, Colombia,  Sri Lanka, Bangladesh,  Jamaica,  Thailand, El
Salvador,  Nepal, Egypt, Eastern Caribbean,  Honduras,  Guatemala,  and Mexico.
In 1984,  A.I.D. implemented  its second  program, Social  Marketing  for Change  (SOMARC).
SOMARC  adopted  a more  systematic  marketing  approach,  shifted  from a distribution-driven  to a consumer-
driven focus,  and solicited  the active  collaboration  of the commercial  sector, not only  to distribute  products,
but also to contribute  financial  and in-kind  resources. Pricing strategies  targeted low-income  cen«sumers
and established  cost-recovery  mechanisms  (Maher et al. 1990).
CSM projects  bring together  all elements  of the retail  chain, including  choice  of distributors,
products,  and brands; creating consumer  demand; and setting prices.  Financial  and technical  assistance
are usually provided  in all areas.
Choice of distributor.  To the extent feasible, CSM capitalizes on existing distribution
infrastructure rather than developing  separate distribution systems.  Most countries have established
commercial  capacity, even if more than one distributor  must be used or the capability  of the system  must
be increased. The selection  of contraceptives  to be marketed  also influences  the selection  of distributors.
In countries where the commercial  infrastructure  is relatively  well-developed,  commercial
distributors  and manufacturers  may be willing to participate in CSM.  These organizations  are already
familiar with marketing and management.  In countries where it is not feasible for a  commercial
organization  to manage  the CSM  project, the project  may be developed  within  an existing  Family  Planning
Association  or other nonprofit  agency. Family  planning  associations  and nonprofit  organizations  often  have
national and local networks, and many are interested in CSM as a  means of supparting their other
programs.
In countries where appropriate commercial  infrastructures  do not exist and there are no
suitable nonprofit  organizations,  it may be necessary  to create a new organization. This means that the
project must pay the organization's  start-up  costs and develop  its management  and technical  systems. An
organization  whose sole  activity  is managing  CSM  may be more focused  on ensuring  the project's success,
but its prospects  for long-term  self-sufficiency  are less promising.
The existence  of an adequate  distribution  system  does not guarantee  the availability  of retail
outlets or that their personnel  are adequately  prepared  to promote  contraception. Some countries restrict
retailers from dispensing  ethical products. For example in Ghana,  only pharmacies  could dispense  pills.
The CSM project convinced the government  to allow oral contraceptives  to be sold in chemical  sellers
shops.
Many  CSM  projects  include  training  pharmacists  and retail  staff. Studies  indicate  that trainees
do master the information,  but it appears  that few of the trained  pharmacists  and clerks pass on what they
have learned to their customers. Training is more eftective  if it includes  communications  skills to help
retailers interact  with consumers  (Maher et al. 1990).
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or market  situations, or even social marketing. CSM is most appropriate for contraceptives  that do not
require clinical intervention,  such as orals, condoms,  and spermicides. IUDs can be added to the product
mix if women are able to purchase  them commercially  and bring them to clinicians  for insertions. CSM
projects  in Indonesia  and Morocco  began with  condoms  because  they  were less  controversial  and had fewer
ethical restrictions;  other methods  were gradually  introduced  later.
The choice of brand directly affects the project's  potential for sustainability  and self-
sufficiency. In countries  that already  have low-priced  commercial  contraceptives,  CSM can work  with the
distributor  of these products  to build its markets,  rather than launching  competing  brands.
Pill projects  in the Dominican  Republic,  Indonesia,  Brazil, Ecuador, and Peru worked with
locally  manufactured  products. Manufacturers  agreed  to lower  or maintain  already low  prices and use their
own  distribution  networks  in return  for donor  assistance  in  building  the market  (Maher  et al. 1990). Donor
funds  were used for advertising,  public  relations,  and research  activities  to expand  the market  for the CSM
product(s). At the end of the project, the manufacturer  is expected  to continue  to sell the product at the
low price and to take over promotion with its own fund..  This is the preferred model when the
prerequisite conditions, an  existing commercial market in contraceptives and adequate commercial
infrastructures,  are present.
When local contraceptive  products are not available  but the commercial  infrastructure is
reasonably  well-developed,  commercial  distributors  may be able to purchase  project  commodities.  Donors
provide funding  to build the market  through advertising  and promotion. This approach is being applied
in Indonesia  (condoms),  Turkey  (condoms),  and Haiti (orals). For example,  condoms  are not manufactured
in Turkey.  The CSM project contracted  with a leading pharmaceutical  and packaged-goods  company,
which agreed to purchase  condoms  with its own funds and distribute  them through its pharmaceutical  and
consumer goods networks.  The condom was registered in country by the Turkish Family Health and
Planning Foundation, and the distributor  agreed to pay a portion of profits from condom sales to the
Foundation. Donor funds will be used to finance  market  research  and advertising  for four years.  By the
end of the project, sales volume should increase to a level where it will be profitable for the local
distributor  to continue  to purchase,  promote, and sell the CSM contraceptive  to the target market  with no
further donor financial  support.
In countries  with low  prevalence  levels  and insufficient  commercial  infrastructures,  it may  be
necessary  to use donated  product to build a market for low-priced  contraceptives. Once the market  has
been built and adequate  reserves are set aside for the future purchase of commodities,  the implementing
agency should be able to obtain contraceptives  through normal commercial  channels.  Donor-supplied
commodities  as well as funding for advertising  and research are provided in Bolivia (orals), Ecuador
(condoms),  and Morocco  (condoms). After the first three to five years, it is hoped  that a sufficient  lower-
income market  will be developed  for the implementing  agencies  to begin to purchase commodities  and to
pay for promotional  support,
In countries where projects will not be able to cover costs of product  or where there is no
access to foreign  exchange, CSM must rely on donated  commodities. In Ghana  (orals, condoms,  vaginal
tablets),  Liberia  (orals,  condoms,  vaginal  tablets),  Trinidad  (condoms),  and Zimbabwe:  (condoms)  economic
conditions  or restrictions  make  it unlikely  that  CSM projects  will be able to obtain  products  commercially.
In Zimbabwe,  donated  commodities  are required  because  of restrictions  on foreign  exchange
rather than undeveloped  markets. Financial  returns that otherwise  could be used to import commodities
are instead reinvested in promotion. The project  will remain dependent  on product donations,  but if a
lower-income  market for CSM products  can be developed,  the implementing  agencies  should be able to
take over future operating  costs of advertising,  promotion,  and research.  In such countries as Ghana,
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sales. In these cases, there will be a continuing  need to subsidize  both commodities  and promotion.
Creating informed consuner  demand.  The objective of any marketing  effort is create
consumer  demand,  in  this  case,  for  modem  contraceptives.  This  requires  market  research  to  track
consumer attitudes and behaviors. Because awareness  is the easiest component  of behavior change to
address, there is a tendency  to respond to any marketing  situation  by increasing  advertising,  and many
projects continue advertising  long after their brand has high recognition.  In Sri Lanka, for example,
advertising  to raise awareness  was continuing  although  Preethi condoms  had about 95 percent awareness
and had practically  become the vernacular  term for condom. Resources should have been redirected  to
satisfying  other informational  needs.
Once awareness  is established,  marketing  should shift to creating interest  in the new product;
providing  knowledge  about its benefits,  how to use it properly, and its source of supply; or encouraging
trial.  This strategy was adopted  in Turkey, where many women already had previous  but unfavorable
experiences  with modern  methods.  Over half of current pill users used higher dose pills which caused
niany side effects. Consumers  and doctors were not aware of low-dose  brands. A mass media  campaign
will promote low-dose  pills, and the project plans to train physicians  and pharmacists  to inform clients
about product  use and side effects.
A similar information  problem  was found in Haiti.  Acceptance  of oral contraceptives  was
high, but continuation  was low.  Women had limited knowledge  of the pill and how it worked; at the
slightest  problem  or side effect  they would  drop or switch  brands, creating  even  worse side effects. A 15-
minute  educational  'soap opera' was produced,  to discredit  rumors and explain  how to use pills  correctly.
Setting prices.  CSM products must be priced low enough to be accessible  to low-income
consumers  without  being so low that  consumers  question  product  quality  or that adequate  profit levels  are
no longer possible.  The ability of the consumer  to pay is the first consideration. A common  product
purchased  by low income consumers-a beer, a bus ticket, a bar of soap or cigarettes-may be used to
establish a  price by analogy.  Income levels may also be used to set prices; a  month's worth of
contraceptives  should not exceed  two percent  of the minimum  monthly  wage.
The next consideration  is cost-recovery.  Prices should aim to cover product costs and
marketing expenses, to ensure that the project will have adequate  resources to continue to obtain and
market contraceptives  once markets  are established. Cost-recovery  pricing usually does not include the
costs of initial advertising  and market  research, which are not intended  to be recouped  from sales.
Pricing decisions  are refined through break-even  analyses  to determine sales volume  levels
where costs will equal revenues at various prices.  If low-income  consumers  can not afford full cost-
recovery  prices, projects  may need to subsidize  prices.  At the least, distribution  costs should  be included
in the price margins and fully covered  by sales revenues.
Evaluation of CSM impact.  During 1988-89, SOMARC funded CSM projects in 29
countries. Table  5 lists the countries  and  products  which  participated. Condoms  were sold in 25 countries;
with the exception  of India  and Indonesia,  all condom  brands  were donated. Oral contraceptives  were sold
in 19  countries; 11 countries  relied solely  on donated  commodities,  six countries  solely  on locally  available
commodities,  and two countries  sold both donated  and locally  available  brands. Spermicides  were sold in
11 countries; with the exception of Colombia and Peru, all  spermicides  were donated.  IUDs and
injectables  were sold in five and two countries, respectively.
Evaluation of the output and impact of CSM has relied heavily on sales data, as the
commercial  sector is driven by volume  and profit margins. Consumer  intercept  studies  are used to assess
the degree to which CSM either attracts  users of other brands or users new to the contraceptive  method.28  Private Sector Approaches to Effective Famdly  Planning
TABLE  5
Location  of SOMARC  contraceptive  social  marketing  projects
and  contraceptive  products  sold




Colombia  D  D,L  D  D  L
Costa  Rica  D
Dominican  Rep.  D  L  D
Eastern  Caribbean  D  D
Ecuador  L
El Salvador  D  D,L
Guatemala  D  D  D
Haiti  D
Honduras  D  D
Jamaica  D  D
Mexico  D
Peru  L  L
Trinidad  D
Sub-Saharan Africa
Ghana  D  D  D
Kenya  D
Liberia  (project  suspended)  D  D  D
Nigeria  D  D  D
Zaire  D  D
Zimbabwe  D  D  D
Asia/North Africa
Bangladesh  D  D  D
Egypt  D  D  D,L
India  L
Indonesia  L  L  D  L
Morocco  D
Nepal  D  D  D
Pakistan  D
Sri Lanka  D  L  D
D =  Donated  product
L  =  Locally  manufactured  or purchased  product
Sales  data  for  CSM  products  are  routinely  collected  in all  SOMARC  projects;  market  data  for  oral
contraceptives  are available  in countries  which subscribe  to the International  Market Survey (IMS). Data
on total sales of condoms  are not available.
There is  no  question that CSM projects have succeeded in  selling large volumes of
contraceptive  commodities.  Table  6 presents  sales  volumes  for oral contraceptives  and condoms  by country
by year.  However, since many of these projects  had begun earlier, it is difficult  to assess the evolution
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TABLE  6
CSM  commodity  sales  (in thousands)  by country,  1988  and  1989
CONDOM SALES  ORAL  CONTRACEPTIVE  SALES
DONATED  LOCAL  DONATED  LOCAL
1988  1989  1988  1989  1988  1989  1988  1989
Latin  America
Bolivia  14  48
Brazil  404  487
Colombia  5474  6588  696  587  4815  4856
Costa  Rica  1905  2186
Dominican  26  290  250  434
Rep.
Ecuador  536  551
El Salvador  1739  1864  155  180  14  43
Guatemala  651  939  67  122
Haiti  252
Honduras  420  491  203  218
Jamaica  1699  2105  510  500
Mexico  2183  1542
Peru  594  714
Trinidad  142
TOTAL  14096  16400  1644  1655  6613  7 0 8
Africa
Ghana  3501  3214  351  431
Kenya  250
Nigeria  607  5944  43  191
Zaire  943  4135
Zimbabwe  50  301  5  32
TOTAL  5101  13844  398  654
Asia/North  Africa
Bangladesh  116711  115152  4704  6692
Egypt  17165  15772  2129  1783
India  13152  41853
Indonesia  7206  7868  46  338
Morocco  280
Nepal  2825  2817  118  161
Pakistan  34030  44314
Sri  Lanka  4833  9501  574  610
TOTAL  175564  187836  20358  49722  6951  8636  620  948
Source:  The  Futures  Group,  SOMARC  project
IMS data are available  from the Dominican  Republic  and demonstrate  the  impact  of the
CSM project on the total commercial market for pills in that country.  In 1986-90, the commercial
market grew by approximately 390 percent.  As can be seen in Figure 3, the increase came from
CSM sales; the other commercial brands remained constant.  Since pre-1985 data are not available,
market expansion in the absence of CSM cannot be projected; however, it is unlikely that it would
have accelerated so rapidly.
CSM projects usually do not include explicit prevalence targets, largely because of the
inherent difficulties in attributing changes in prevalence to specific interventions, and because the
commercial  market  is more  concerned with  sales.  Nevertheless, from the  donor  perspective,
evaluating project impact on prevalence or market share is essential to justifying continued support
to CSM efforts.
Consumer intercept studies are used to assess impact of CSM on source switching and30  Private Sector Approaches to Effecive Family Planning
FIGURE 3
Impact of CSM on commercial pill market in the Dominican Republic
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on attracting users  new to the  contraceptive method.  Consumers purchasing CSM products  in
pharmacies and shops are interviewed on the spot for their socio-demographic characteristics and
previous use of contraception.  However, it is not immediately  clear that new users have adopted the
CSM method and brand because the program is promoting low-priced  commodities  or because buyers
are at the stage of life to begin using contraception  and purchase the CSM brand over another.  New
users have been reported to be younger than women who switch from other brands in the Domini-
Republic, Honduras, and Peru; the alternative hypothesis that they would have begun contracepting
without the CSM project cannot be discarded (Brown et al.  1988).  In intercept studies in the
Dominican Republic and Peru, 34 percent of the CSM brand purchasers in each country reported that
they had not used any family planning method before using the CSM brand.  However, these figures
do not distinguish between first-time purchasers and long-term users: 46 percent of the respondents
in Peru had been using the brand for over one year, and 11 percent for five years or more.  These
studies should disaggregate first-time purchasers for separate analysis.
Finally, the impact of increased prevalence of CSM methods should be assessed against
the background of total contraceptive prevalence.  It appears that in the Dominican Republic and
Panama, women may  have begun to  postpone sterilization because of greater  reliance  on oral
contraceptives (Brown et al.  1988).  In this case, CSM could be seen as promoting greater user
choice and quality of care, but its impact on fertility would be diminished.
In Honduras, pill prevalence remained unchanged three years after the introduction of
the CSM project (12.7 percent in 1984 vs.  13.4 percent in  1987) (Honduran Ministry of Public
Health et al.  1989).  The social marketing share of the pill market more than doubled, from 6.5 to
15.4 percent.  CSM drew clients from the public sector (20.9 to 17.8 percent), the commercial sector
(26.4 to 21.0  percent), and  the CBD program (46.0 to 41.3 percent).  Thus  project success in
attracting previously  subsidized  users  (public and  CBD  clients) was  nearly  offset  by  source
substitution from the self-supported commercial sector.
The degree to which CSM projects increase total method prevalence and/or effect source
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and  relative  prices.  It  is an  issue that  warrants  further  study.  Definitive evaluation of  the
contribution of social marketing to  contraceptive use requires that sales analyses and consumer
intercept studies be conducted in the context of a  wider research effort, including contraceptive
prevalence surveys that include better questions on source and financing and consumer responses to
changes in relative prices.
Three CSM projects have terminated donor support and are therefore considered to be
self-sufficient: Dominican Republic (orals), Barbados, and Indonesia (Dualima condoms).  It should
be noted that USAID/Indonesia has begun to finance a $4 million, four-year social marketing project
to  promote  another  product  line  which  will  directly  compete  with  the  earlier  CSM  brand.
Stipulations that commercial partners will pick up promotional costs once project funding terminates
have been made in Colombia, Ecuador, Bolivia, Brazil, the Dominican Republic, Peru, Indonesia,
Morocco, and Turkey.  Data on commercial  investments  are not forthcoming. Companies regard such
information as trade secrets and do not reveal expenditures so that their competitors do not find out
what they are doing.
Projects which do not achieve full self-sufficiency may be able to demonstrate that the
CSM channel is less expensive than other subsidized approaches.  For example, in Honduras, the
gross direct cost of distributing oral contraceptives via social marketing was 16 percent lower than
the implementing agency's CBD program; when net costs were calculated by subtracting revenues
earned, the cost differential increased to 34 percent (Janowitz et al.  1991).  Colombia Profamilia's
CBD program works very much as a  CSM approach; the costs of distributing temporary supply
methods through the CBD program were two to almost four times cheaper than distributing the same
methods through its clinical outlets (Chernichovsky and Anson 1989).
4.3.2. Subsidies  to private  practitioners,  medical  groups, and employer-supporled  health plans
Donor subsidies to commercial health outlets have been tested on a pilot basis in the
hopes that these organizations would assume full costs once the  market was established.  Some
projects attempted to increase demand for family planning, and others attempted to establish a wider
supply base.  Most of these projects have worked with third-party financing and organized medical
groups, although one project in Mexico worked with individual private physicians.
In Indonesia, the Atma Jaya Hospital provides family planning to  factory workers,
mostly young women, in North Jakarta.  In 1983-87, all service delivery costs were picked up by
a donor, Family Planning International Assistance (FPIA).  When funding ran out, the project turned
to the Asia Family Planning Operations Research project and TIPPS for  financial and technical
assistance to market the same services, but with employers paying the service delivery costs.  During
the next two years, 27 factories signed up for health services, 17 of which contracted for family
planning.  Over 4,000 clients received family planning in the first 18 months.  A slight increase in
contraceptive prevalence (69.9 to 73.1 percent) was reported after the first six months, but this may
have resulted from sampling error.  More significantly, the project succeeded in attracting previous
users of public facilities: the percentage of users who were served by government clinics dropped
by a third (44 to 29 percent).  The services also attracted previous users of commercial outlets; the
percentage served by  the  commercial sector dropped  by  almost a  quarter  (37  to 28  percent).
Revenue generated for Atma Jaya exceeded costs by the end of the first month (Hindarto et al. 1990).
In the Philippines, the Enterprise Project provided subsidies to an umbrella NGO, the
Population Center Foundation (PCF) to market family planning services to nearby factories.  Within32  Private Sector Approaches to Effective Family Planning
two years, 21 companies had been enrolled.  However, service costs were still highly subsidized by
the donor; less than  15 percent of the operating costs were being recovered from employers.  A
similar umbrella project in Tbailand with the Population and Community Development Association
has  run  into  sustainability problems.  The  program was almost totally donor  funded, and  as
employers were not liable for health and maternity (these costs were covered by the national social
security system), the participating firms had very little incentive to avert unwanted births.
Health insurance companies in Peru do not offer preventive care.  The TIPPS project
provided seed  money to  Medicsa,  a  private  medical group  in  Lima that  serves private health
insurance clients.  Medicsa promoted the  financial benefits of family planning with employers,
insurance companies, and administrators of self-insurance funds.  As an incentive, the price of
outpatient consultations for family planning was set at 50 percent of the normal tariff and the project
offered a family planning educator to promote  the new services within client companies. The project
convinced two insurance companies and two bank self-insurance funds to include family planning.
Benefits were continued even after price subsidies were withdrawn.  Acceptance by individual users
was slow,  due  in part  to the  higher deductibles and  co-payments demanded by  the  insurance
companies in response to Peru's worsening economic conditions.  While the project did succeed in
incorporating family planning into some health insurance plans, it might have been more effective
to work directly with the insurance companies themselves.  Since the clinic benefitted from selling
additional services, their credibility in promoting cost-benefit arguments may have been suspect.
In Brazil, the Pathfinder Fund and TIPPS collaborated on a project to introduce family
planning into ]HMOs. Prepaid plans are the major source of employer-financed  health care in Brazil.
These organizations routinely cover preventive care, including  prenatal and well-baby visits, although
few offer family planning in an organized fashion.  A cost-benefit analysis performed at one of the
larger HMOs found that due to high levels of existing contraceptive prevalence and resultant low
fertility rates, incorporating family planning  would avert relatively few births and achieve only a very
modest benefits to costs ratio (AMICO 1987).  However, family planning could reduce the rate of
cesarean section deliveries and induced  abortions; the operational  advantage  to the organization would
be  to shift patient load from hospital to outpatient clinics.  Since outpatient clinics are easier to
manage, this argument proved attractive; currently, 17 HMOs have incorporated family planning  with
commodity support from the Pathfinder Fund.  Long-term prospects hinge on the development of
cost-containment strategies for offering family planning.
In  their  literature  review,  Rinehart et  al.  (1987) found that  relatively  few of  the
companies that had received donor subsidies to offer family planning had "graduated" to supporting
the programs with their own funds, and that many of those that had, continued to receive commodity
support from government or NGOs.  Skibiak's (1991) end of project review of the Enterprise project
was more positive.  It lists 17 subprojects which had begun to sustain family planning after subsidies
ended, and only two that had not.  Employers' contributions ranged from 12 to 164 percent of the
donor subsidies.  Median employer contribution among the sustainable group was 49 percent of the
donor subsidy.
4.3.3.  Public-pnivate  sector  partnerships
The most usual form of public-private partnership is one in which a  private group,
usually an NGO,  arranges to use a  public facility-and  sometimes public personnel as well-to
provide  family planning services.  Many of these arrangements are informal, and  there are few
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program was run out of the state secretariat of health, using publicly paid "volunteers" to distribute
contraceptives out of health posts and municipal centers (other CBD posts include promoters' homes
and market stands) (J. Foreit et al.  1983).
In Peru,  an operations research project arranged for a local NGO, Vecinos Peru,  to
operate after-hours family planning clinics  in three  ministry of  health hospitals in  the  interior
highlands.  The ministry provided facilities, and the NGO provided commodities and equipment,
trained service delivery personnel, and paid salaries.  In the first year of operations, new family
planning acceptors increased by 200-700 percent over baseline levels.  The after-hours clinics were
especially popular with men, who were unwilling to attend in the mornings, when family planning
shared waiting and examination rooms with gynecology and obstetrics.  Acceptance of all methods
increased in the experimental sessions, and temporary supply methods-especially  condoms, due to
the higher numbers of male clients-showed  the largest increases.  Operating costs were extremely
modest, approximately US$7,000/year per clinic (Solari et al. 1989).
In Honduras,  the IPPF  affiliate,  ASHONPLAFA, initiated a  voluntary sterilization
program in  1977, supplementing its own two clinics with 16 other  hospital locations belonging
primarily to the Ministry of Health (private hospitals are also used).  National prevalence of female
sterilization was  12.6 percent  in  1987; half of  these women had  received the procedure  frc.m
ASHONPLAFA in a ministry hospital (another 5.5 percent were operated on in the ASHONPLAFA
clinic and  15.6 percent in a private hospital staffed by  ASHONPLAFA) (Honduran Ministry of
Public Health et al.  1989).  The NGO also utilizes some ministry personnel in its CBD program;
approximately 3 percent of the users of oral contraceptives obtained their supplies through the CBD
program operating out of ministry facilities.
4.3.4.  Privatizaon
Privatization of family planning services has been explored in only a few countries.
Lewis and Kenney (1988) were able to find only three examples: contracts with private physicians
in Korea (for sterilizations) and Taiwan (for sterilizations and IUD insertion), and an arrangement
in Nigeria  whereby a  private pharmaceutical firm  handles the  distribution of contraceptives to
government facilities.
In other countries, the public sector routinely contracts out for health care. For example,
the Brazilian social security system (INAMPS) contracts with private providers for 43 percent of its
outpatient care and 82 percent of its inpatient care (Lewis 1991).  Family planning services could
easily be integrated into these arrangements. Similarly, the social security administration in Uruguay
contracts  with  HMOs  for  health  care  services.  Outside Latin  America,  a  limiting  factor  to
privatization of health services, and hence family planning, is the size of the private sector.
5.  Impact  of enhanced  private sector  participation
The challenge to  family planning programs is to  serve ever-increasing numbers of
contraceptive users.  In those few countries that already have achieved high prevalence, this means
keeping pace with population growth and perhaps improving the contraceptive method mix.  In most
developing countries, however, it will require not only keeping up with population growth but also
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The potential family planning market includes current users of public and private sources
as well as unmet need, those women and men who either want no more children or wish to delay
the next birth but are not practicing appropriate contraception.  The impact of increasing private
sector  participation  on  satisfying unmet  need  for  family  planning,  and  thus  on  raising  total
prevalence, may sometimes be indirect and difficult to measure.
<-  EXISTING  MARKET  ->
Public  Private
Sector  Sector  Unmet  need  for  family  planning
Users  Users
POTENTIAL  MARKET  >
The basic hypothesis is that stimulating the private sector will increase the number of
private sector users.  This may be accomplished by attracting users from the public sector, and/or
recruiting nonusers of family planning.  The first alternative is market restructuring; the second is
direct market growth.  As the number of users served by the private sector increases, so does its
market share (unless, of course, the public sector grows even more rapidly).
If the private sector succeeds in attracting previous public sector users, it is expected that
the public sector in turn  will use its  newly freed-up resources to  recruit  new family planning
acceptors (previous nonusers).  Thus the  number of users served  by the public sector will  not
markedly decrease, although some decline may occur if the new acceptors are more expensive to
recruit and serve than the users who passed to the private sector.
Removing or reducing subsidies to those who  do not need them  should benefit the
commercial sector, which does not depend on direct government or donor subsidies.  This in turn
should improve the sustainability  of the national family planning program.  An expanded commercial
market benefits local manufacturers of contraceptive commodities, private service providers, and
NGOs  (to the extent that they take advantage of new opportunities to  market their services and
generate income).  The impact of an increased private market on quality of care and effectiveness
of the contraceptive method mix remains to be seen.
The desirability of increasing private sector participation does not negate the need for
government involvement in family planning. Attracting users from the public into the private sector
allows the public sector to expand its coverage, by increasing outreach to previously unserved and/or
underserved populations.  The public sector should not decrease its family planning funding as a
result of source substitution.  To the extent that previous public sector users who  passed to the
private sector are replaced by nonusers of family planning, contraceptive prevalence will increase.nmpact  of enhanced  private  sector  particIpadon  35
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Choosing appropriate interventions depends on which part of the private sector is to be
addressed.  Inputs to the nonprofit sector usually take the form of direct  subsidies or technical
assistance.  However, the commercial sector requires a different approach, as most donors do not
wish to invest directly in firms that are already making a  profit, and without this kind of fiscal
leverage, it is difficult to "order" the sector to expand its coverage.  Therefore, commercial sector
initiatives are usually more indirect and may take the form of incentives or promotion.  This may
include legal and regulatory reform to remove obstacles to commercial sector participation, positive
incentives such  as tax  breaks,  or  using  cost-benefit analysis to  encourage private  health  care
financiers such as employers and insurance companies to invest in family planning.
5.1.  Impact  of increased commercial  sector participation
As described earlier, the commercial sector is already involved  to varying degrees in all
aspects of family planning from manufacturing contraceptive commodities to their promotion and
distribution.  In larger and more industrialized countries, local manufacturing and/or packaging of
contraceptives may prove cheaper to donors in the long run than continuing to export commodities
from developed countries.  The private sector will and should probably play a  lead role in the
development of in-country manufacturing capacity.  It has been argued that an equity involvement
by  a  private  sector  technology  supplier can  help  ensure  maintenance of  international quality
standards, and that the profit orientation of the private sector will motivate expansion of sales (and
hence increase method prevalence) to utilize production capacity (PATH 1991).
Many countries will find it advantageous to increase commercial sector participation in
promotion and distribution of contraception.  Commercial outlets can do  more than broaden the
funding base for family planning.  Because of their strong incentives to minimize costs, they may
also be able to serve clients more efficiently than the public sector.  Increasing commercial sector
participation may increase the number of family planning outlets and diversify the method mix.  To
the extent that clients who pay for goods and services are more demanding  and stimulate competition
among  providers,  commercial participation in  family  planning may  improve quality  of  care.
Commercial providers may also assist in creating a wider demand for specific contraceptive methods
using proven marketing techniques.
Traditional views on the inability or unwillingness  of lower-income  groups to pay at least
part of the costs of the social services they consume have been challenged in health (Akin et al.
1987).  As Lewis and Kenney (1989) point out,
The traditional assumption that commercial delivery of contraceptives serves the urban,
upper classes and sets charges that are only affordable to that segment of the market has
never been examined.  There is very little information on the source of contraceptive36  Private Sector Approaches to Effective Family Planning
services, or what users pay  in developing countries, because most survey work has
focused on utilization patterns and trends.  How consumers get their services, who pays
for it, and the availability and effectiveness of alternative sources of services are issues
that have not been addressed in any depth (p.43).
At  the very least,  governments should consider increasing the commercial share of
supply methods.  For example, in Thailand, the government currently controls 70 percent of the pill
market.  It that share were reduced to 28 percent (the blean for Latin America), 8 percent of the
current users of mede,rn methods would have moved from public outlets to pharmacies, more than
doubling the current market share of the  latter (from 7 to  15 percent).  Janowitz et al.  (1990)
estimate that if, by the year 2000, the source mix in Asia were to follow the commercial pattern
found in  Latin America in  1985, public and PVO program costs  in that region would actually
decrease,  despite higher prevalence and increased use of modern methods.  Similarly, increased
commercial participation in Sub-Saharan Africa could reduce anticipated public and PVO costs by
10 percent.
On the down side, the commercial sector cannot satisfy a country's entire need for family
planning because many low income households will continue to be effectively priced out of the
market.  It is unlikely that commercial family planning outlets will have any incentive to  reach
households entirely outside of the cash economy.
Health demand studies have clearly demonstrated that  many individuals obtain their
goods and services through the commercial sector.  The commercial sector has the potential to
produce contraceptive commodities and to deliver family planning to people who already obtain
health goods and services from commercial outlets, keeping in mind that a single individual may use
a variety of different health outlets, both public and private, depending on the nature of the health
problem and the required intervention, prices and opportunity costs, perceived quality, competing
sources, and other factors.
5.2.  Impact  of increasing NGO participation
NGOs can provide a useful adjunct to the public sector in providing family planning for
low-income consumers and can often undertake promotional activities that governments may avoid
for political or institutional reasons.  However, care must be taken not to use donor subsidies to
compete with the commercial sector.  For example, in Latin America, where both the commercial
and PVO sectors are well developed, NGOs compete with pharmacies for pill users (correlation
between pharmacy and NGO  market share,  r  =  -.516) and  with private physicians for  female
sterilization (r  =  -.525).  In contrast,  no  interaction can  be seen between  NGOs and  private
practitioners for I13) users (r  =  -.037).
NGOs could benefit from hands-on technical assistance  to position themselves  better with
respect to their markets.  This would allow them to adopt a marketing strategy consistent with their
level of development and the needs of the national family planning program.  Three basic options
are  available: price  leader  (offering products  at  a  price  lower  than  the  competition); market
segmentation (finding a  niche not being served by  its  competition; this  niche may  be defined
geographically, by  income, or by  other consumer characteristics); or differentiation (charging a
higher price for a higher quality product or for a well-known label).
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to  the extent that costs are  underwritten by  donor  support and  only nominal fees are charged.
However, this strategy will not allow NOOs to become financially secure unless they know what
their costs are.  Given NGOs' orientation to serve lower income groups, the differentiation strategy
is usually not viable, unless the competition is only no-cost public services.
In  areas  of  higher contraceptive prevalence,  NGOs should concentrate on  market
segmentation strategies, targeting their efforts at specific income groups in specific geographic areas.
Donor subsidies and commodities  permit NGOs to offer family planning at below market prices and
to reach many areas relatively unserved by either public or private outlets.  It is critical that each
agency concentrate its efforts in well-defined  zones; trying to cover large geographic areas often only
increases the agency's complexity without achieving economies of scale.
5.3.  Impact of increasing social marketing
Experience to  date has  demonstrated that donor-subsidized promotion can increase
commercial sales of contraceptive commodities. Long-term prospects for CSM depend on the ability
of newly established or enlarged markets to support commercial sales once donor subsidies have been
removed, or on the willingness of governments and donors to continue  to subsidize social marketing.
Self-supported CSM efforts can contribute to  higher contraceptive prf-valence both directly,  by
increasing the total market for the methods being promoted; and indirectly, by attracting users of
subsidized sources who can afford to pay for their methods, thereby freeing up these resources to
serve a  needier and  currently unreached population.  Subsidized CSM can contribute to higher
contraceptive prevalence if its costs are lower than other subsidized channels for the same methods.
The extent to which a CSM effort can ultimately become self-sufficient depends on such
interrelated  factors  as  participation  of  commercial  distribution  and  retail  networks,  using
commercially acquired (not donated) commodities, and prices which permit at least a small margin
of profit.  CSM must be rooted in the commercial sector if it is to  continue without donor or
government support.  This obviously requires that there be a functioning commercial sector.  Latin
America provides the best opportunity for commercial sector transfer.  CSM prospects in Africa are
complicated by the lack of a  dynamic commercial retail sector and a dearth of management and
marketing skills.  Many countries are wary of private enterprise, such as Zimbabwe, where the
government is suspicious of measures that benefit the private sector.  The problem in Asia is one of
government domination of family planning.
Heavy  involvement by  public sector  and  NGOs have  often  coincided with  major
implementation  problems for CSM (see Brown et al. 1988). Population programs in Asia have long
been the domain of the government. Like any commercial enterprise, CSM programs are negatively
affected when governments provide free goods to users who can afford to pay.  For  example,
activities  in  Indonesia were  hampered until  physicians and  midwives were  permitted to  sell
contraceptives, thereby eliminating the free supply and increasing the number of CSM distribution
points.
Pricing is another critical issue.  Retail prices are paid by consumers; if they are too
high, consumers may not be willing or able to pay them, and if they are too low, producers and
distributors cannot make a profit.  Onlv a few CSM projects have been able to become self-sufficient
for commodities; asking the comme;cial sector to foot the bill for promotion as well is even more
difficult.  Cross-subsidization of lower-price by higher-price products has  been suggested as a
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class consumers may prefer the lower-priced CSM brand.  The incentive to retailers is to sell the
higher-priced  items. As a result, companies  may  be tempted  to raise prices rather  than developing
product  line extensions  for more  affluent  customers,  once  donor subsidies  have  been  withdrawn. If  L
the project  has successfully  established  a viable  low-income  market  and positioned  products  for that
market,  commercial  firms should  more than make  up in volume  what they lose in profit margins.
It remains to be seen if they will in fact do so.
5.4.  Impact of increasing managed medical care participation
Recent experience has shown that even in times of economic crisis, there are private
employers and health underwrite.s who can achieve significant cost savings with family planning.
Urban employers must be convinced that their workers need family planning assistance.
For the short  and medium term,  increased participation of insurance companies and
managed medical care in family planning is more likely to affect market segmentation than to lead
to market expansion. Outside of Latin America, the vast majority of the population is either outside
the formal labor force or not covered by employer-sponsored medical benefits, and those who are
covered are also more likely to already be using contraception.
This  is not to suggest that donors not work with this sector, but quite the contrary.
Providing technical assistance to  employer plans is a  relatively low-cost activity,  and  if direct
subsidies are not provided, whatever family planning activities that are begun, are likely to continue
without donor support.  Implementing  family planning  in this context is time-consuming  ar`  Nuires
continuous one-on-one contact and follow-up with both top and middle management. It may take one
or two years between presentation of cost-benefit analyses and initiation of services.  Furthermore,
it should be kept in mind that employers and health underwriters are, not in the family planning
business.  No  matter what the company's concern with employee welfare,  family planning will
always be a low priority.
The impact of providing subsidies to companies unwilling or unable to make the initial
family planning investment is still not clear.  The limit or upper bound to this activity is the size of
the formal labor force; the viability of the approach depends on reducing costs and/or attracting hard-
to-reach audiences, such as young men.
5.5.  Impact  of public-private  partnerships  and  privatization
The impact of public-private partnerships on contraceptive use is difficult to assess,
principally for lack of data.  Prevalence surveys routinely ask users for their family planning outlets
but seldom ask about source of financing.  Consequently, clients tend to be classified by the location
of their provider rather than by who actually paid the bill.  This may lead to overestimating either
the impact of the private sector, in the case of public subsidies paid to private practitioners operating
out of private facilities, or overestimating the impact of the public sector,  in the case of private
practitioners operating out of public facilities.
NGOs  operating  special  family  planning  sessions  in  government  facilities  have
significantly increased program coverage in Honduras and Peru (Honduran Ministry of Public Health
1989; Solari et al.  1989).  In an operations research project in Indonesia, government fieldworkers
referred clients to private midwives for clinical methods.  Although 29 percent of the fieldworkers
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been referred  by  a  fieldworker (see Lande  1991).  On the  other  hand,  in Taiwan,  where the
government has  a  long-standing policy of reimbursing private practitioners for  family planning
services, most IUD users receive their method from the private sector (Lewis and Kenney 1988).
The success of public-private partnerships ultimately depends on a  number of factors, such as the
availability of private providers, amount of subsidies offered, and red tape and delays encountered
in applying for reimbursement.
6.  Appropriate  policies to support  private sector services
The active participation of the private sector benefits family planning because it can (a)
expand  the  total  family  planning  market  to  help  satisfy  existing  and  future  unmet need  for
contraception; and  (b) shift current users from subsidized to more nearly self-supporting outlets
without compromising coverage, equity, and quality of care.  Therefore, it is to the government's
advantage to encourage greater private sector involvement  in the national family planning program,
although the mechanisms (NGOs, retail outlets, private providers) and mix will vary from country
to country.
Government has a legitimate role in regulating private sector family planning activities,
such as licensing facilities, maintaining professional standards among practitioners and quality of
contraceptive commodities.  Disseminating  information about the benefits of fertility regulation and
contraceptive options is the responsibility of the government, as is support to users who are excluded
from private markets because of geographic isolation or inability to pay.  However, governments
should not be in the position of subsidizing either users or producers/distributors of contraception
who would maintain their family planning behavior even without government support.  As Akin et
al.  (1987) point  out,  many government health  subsidies actually  favor the  geographically and
economically privileged, although this  is probably less true of family planning.  Overly strong
government family planning support may act as a deterrent to private sector coverage (Cross et al.
1991).
The kinds of private sector activities that donors should support depend in part on which
contraceptive methods are to be emphasized. For example, nonclinical systems are the most efficient
way to distribute supply methods, as long as medical backup is available for women who suffer side-
effects or who wish to switch to another method.  For the vast majority of pill and other supply
method users, it makes no sense to tie up expensive clinical facilities and scarce medical personnel
for resupply.  Nonclinical distribution favors commercial systems in urban and periurban settings  and
CBD systems (either public or private) where commercial networks break down.  Price subsidies
might be considered in areas served by commercial systems, but where consumers cannot afford
prevailing commercial prices.
Provision of sterilization, especially  tubal ligation, is closely linked  with existing  hospital
infrastructure, which in many countries favors the public sector.  Underwriting the construction of
private free-standing clinical facilities for  sterilization may be a  risky undertaking, aspecially in
settings without a demonstrated demand for sterilization services or with limited ability to pay.  In
poorer countries that lack hospital networks, sterilization may not be a viable large scale option in
the short run and be confined to secondary and tertiary hospitals in larger urban areas.  Roving
sterilization camps have proved effective  in Nepal and Thailand where demand for the procedure was
high; however, they may have backfired in other areas such as India.  Mobile clinic vans have been
tried in such countries as Colombia and Guatemala, but their effectiveness and cost-efficiency has40  Private Sector Approaches to Effective Fandly Planning
not been carefully analyzed.
IJDs  are sensitive to existing infrastructure but can be removed frokn clinical settings.
If minimum hygiene standards are observed, IUDs can be safely inserted in almost any facility that
contains some kind of examining table and adequate illumination.  This favors  NGOs that use
nonphysicians and  nonclinical outlets.  IUDs can also be easily integrated into existing medical
outpatient facilities, such as solo physician practices, group practices and HMOs,  and company
clinics, if adequate financing is available.
Strategic donor planning for program expansion  must consider specific methods, specific
consumer groups, and all potential outlets, not only broken down by public and private sectors, but
also by different components within the private sector and various possibilities for public-private
sector interaction.  Governments can enhance private sector participation by removing obstacles and
providing direct support and incentives to private markets.  This requires that the private sector and
its components (NGOs, retail outlets, modern and traditional practitioners) be explicitly included in
all health and family planning sector analyses and that serious consideration be given to the potential
impact of increased government family planning programs on existing private sector activities.
Government and donor support to the private sector can take two forms, that of work
in the  policy arena to  foster a  favorable environment for  private sector participation in family
planning, and providing or facilitating financing and other support for private sector activities.
6.1.  Policy initiatives to promote  private  sector participation
Two policy areas which have important implications for private sector family planning
activities are strategic planning and legal and regulatory reform.
6.1.1.  Strategic planning
1.  Increase government awareness of the potential  of the private sector
to serve more family planning users and improve the quality of
information available for decision making
The  private sector,  and  especially the  commercial sector,  is the  major  source  of
contraceptive goods and services in most of Latin America, an important factor in Asia and North
Africa, and an emerging force in Sub-Sabaran Africa.  Nevertheless, most governments continue to
omit private providers from national family planning strategies and programs.  If donors wish to
achieve  policy  reforms  to  stimulate private  investment in  family  planning,  they  must  assist
governments to evaluate the extent of current private sector activities, as well as the obstacles and
incentives to wider participation. Further analysis of national survey data, such as the Demographic
and Health Surveys, is a key; family planning should be included in all future health sector analyses,
and vice versa.  Better understanding is needed of the factors that influence consumers' selection of
outlets for a variety of health behaviors, including, for example, treatment of minor illnesses, well-
baby care, prenatal and m..ernity care, and family planning.
2.  Assess the  potential impact of expanded public family planning
services on  private  sector  producers,  distributors,  and  service
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This paper has stressed the negative consequences  of expanding subsidized goods and
services in areas already served by the commercial sector.  However, positive effects of increased
public involvement may also be possible.
a.  Local manufacture of contraceptive comnodities.  By the year 2000, approximately
492 million contraceptive users will be found in areas that historically have relied heavily on donated
commodities.  In designing contraceptive procurement plans, donors should consider the possibility
of local manufacturing; when production is not feasible, local packaging and quality control may be
possibilities.  Ninety percent of current developing country users reside in only 16 countries, all of
which  already  have  large  enough consumption to justify  local production.  Locally produced
commodities can be sold to donors, the public sector, and ultimately, retail distribution chains.
Any assistance effort promoting local production of contraceptives should assess both
the reliability of the projections of demand for contraceptive commodities and production capacity,
as well as the incentives and constraints to local manufacturing within the given country.
b.  Avoid introducing  subsidies into areas already  served by the private sector. Demand
for contraception appears to be relatively inelastic to small price increases, but the reverse may not
be true.  Experience in Brazil found that introducing free commodities into areas with a small retail
sector had the undesired effect of driving out the commercial sector without increasing prevalence
(Rodrigues et  al.  1979; Arruda et  al.  1982).  Baseline commercial distribution data should be
collected before designing or increasing government subsidies; if survey data are not available, local
distributors may be able to provide some estimate of commercial sales.  Controls should be instituted
to prevent leakage of donated commodities into the private market; if donors wish to furnish retail
outlets with donated supplies, it should be done on an organized rather than informal basis.  Donors
should provide technical assistance in logistics and continuously monitor destinations and outcomes
of donated commodities.
c.  Reduce  unnecessary subsidies.  Public family  planning  programs  and  donor
subsidized NGOs should consider instituting means testing and user fees to discourage inappropriate
utilization of public sector resources. In addition to generating income for public facilities and NGOs
(itself a  major concern  for health care financing efforts), charging for  goods and  services may
convince some less-needy users to switch to private outlets.  Subsidy reduction should be attempted
only in higher prevalence areas or in more mature programs; programs should conduct small OR
projects to test the impact of charging on utilization before setting system-wide fees.
3.  Assess existing  public sector coverage  before  introducing new
subsidized NGO outlets
If NGOs are to expand geographic coverage of the family planning program, priority
should be given to areas currently unserved by the public sector.  This will almost necessarily raise
the cost of support services such as logistics and supervision and therefore increase per-user costs
as well.  Many times, NGO outlets duplicate public services, and more isolated communities  continue
without any services at all.  For example, a community-level analysis of the 1987 Ecuador DHS
found that half of the rural CBD promoters were located in communities  already served by a Ministry
of Health subcenter while 71 percent of the rural segments had neither MOH nor CBD services. The
presence of either an MOH outlet or a CBD promoter raised contraceptive prevalence, but when the
services were combined, the effects were less than additive (CEPAR 1989).42  Private Sector Approaches to Effective Family Planning
4.  Encourage private insurance and prepaid medical plans to include
family planning services
Insurance or risk coverage plans have been advocated as a means of extending health
care to low-income households; however, the recommendations  usually cover only protection against
catastrophic events.  Preventive care is often deliberately excluded (see Akin et al.  1987).
There are situations where it does make sense for risk-sharing insurance plans to provide
family planning coverage;  for example,  if plans cover maternity care  or treatment of abortion
complications, providing low-cost family planning services might reduce these higher-cost claims.
Prepaid medical plans, such as preferred provider or health maintenance  organizations, may also have
net gains from family planning.  Donors can help determine the costs and benefits associated with
family planning for insurance, prepaid medical, and employer-subsidized  health care plans; however,
care must be taken to avoid subsidizing studies or services that the plans would otherwise finance
themselves.
6.1.2.  Legal and regulaory  reform
Public policies and regulations may constrain the growth of the private family planning
sector by shifting the supply and demand curves inward, reducing the level of actual goods and
services provided by the private sector from their true potential.  Many of these regulations lie
outside the scope of family planning or even the health sector and bring into play other government
ministries and departments (e.g.,  ministries of finance or planning commissions) whose objectives
may be at odds with those of the family planning program.  Furthermore, some regulations which
exist on  the books may  not be honored in practice (such as selling pharmaceuticals only with a
physician's prescription), and there are a host of nonregulatory economic factors, such as disposable
household income and the availability of free public services, which may have a  greater limiting
impact on the private sector than government policies.
Kenney (1990) has identified seven regulatory areas that may inhibit the expansion of
private family planning efforts:
1.  Import  policies, including  tariffs or quotas on imported  family planning  supplies and
other import restrictions such as controls on foreign exchange.  These serve to raise retail prices of
contraceptives and medical services such as IUD insertions or sterilizations in countries that are
heavily dependent on imported commodities and equipment.  Import controls are often imposed as
part  of structural  adjustment or  as conditions for  receiving  foreign  assistance; donors  should
considering exempting family planning products or adding contraceptives  to the list of exempt basic
medications.  In larger countries, local manufacture of contraceptives may be a viable alternative to
lifting import restrictions, providing that critical machinery can be brought in.
2.  Tax policies,  such as value-added taxes.  These also serve to raise retail prices and
may  have  a  negative  impact  on  efforts  to  establish  a  local  capacity  to  package  imported
contraceptives and to perform quality controls.  While ministries of finance are loathe to forgo any
potential source  of revenue,  if  basic medications are  exempt from sales or value-added taxes,
contraceptives  should also be; in addition, donors could demonstrate  that the loss in tax revenue from
local  manufacture  or  packaging could  be  offset  by  other  economic  gains  such  as  expanded
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3.  Pricing  policies, including  price ceilings or other price controls. Many governments
control the  prices  that  can  be  charged  for  basic  necessities,  including certain  foodstuffs and
medications.  During times of inflation, these restrictions may keep the selling price below the cost
of production and force manufacturers out of the market, or make profit margins so small as to
discourage retail distribution and sale.  Relaxation or elimination of price controls is often included
in structural adjustment programs.
4.  Advertising restrictions may prohibit mass media promotion of brand-name ethical
products, product lines, or even nonprescription family planning products.  Donors interested in
underwriting social marketing efforts may need to address advertising policies.  However, given the
small profit margins for  most contraceptive brands, it is unlikely that many private manufacturers
or distributors would invest heavily in mass media advertising even if restrictions were tifted.  For
similar reasons, few private companies would be willing to invest in generic advertising campaigns.
5.  Certication  of outlets and providers may limit family planning distribution to fully
equipped clinics,  licensed physicians, or pharmacies.  These regulations are often supported by
professional  associations to  restrict  their  competition.  NMOs,  noncinical  programs  such  as
community-based distribution, and social marketing programs are often affected by  certification
requirements; donors may find it easier to approach regulatory bodies directly rather than to try to
work through the professional associations. Certification issues may also be encountered  when trying
to establish free-standing sterilization or abortion facilities, even though the procedures themselves
are permitted by law.
6.  Delays In approval of new products  affect both donors and recipients. For example,
A.I.D. cannot distribute, except for clinical trials, any pharmaceutical  not approved by the U.S. Food
and Drug Administration.  Similar delays may be encountered within developing countries; for
example, Brazil manufactured and exported the TCu 380A copper-bearing IUD for several years
before the device was permitted for  use  in country.  It is not clear to what extent donors  can
encourage governments to  streamline the approval process,  but they  can help assure  that once
approved, import licenses are routinely renewed.
7.  Restrictions  on  private medical practice,  ranging from total bans on private practice
to restrictions on certain types of practitioners.  These may be imposed to insure an adequate supply
of practitioners for the public sector or because of a government's ideological commitment to free
public health care.  At a minimum, donors can encourage governments  to permit public practitioners
to maintain private practices in their off-hours.  Many practitioners already do engage in private
activities in spite of official prohibitions, and government  recognition would allow public authorities
to exercise legitimate licensing and quality controls.
6.2.  Funancing initiatives to promote  private  sector participation
6.2.1.  Foster demand for private sectorfamUy planning goods and serices
Demand  can  be  created  at  different  levels:  for  fertility  regulation,  for  specific
contraceptive methods, and for specific contraceptive brands and/or outlets.  Creating demand for
fertility regulation and improving knowledge of contraceptive options is properly the work of the
public sector to correct imperfect information  and should be publicly financed. Improving consumer
knowledge of specific contraceptive brands and/or outlets may benefit private sector products and
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motivate companies to invest heavily in mass advertising.  Publicly funded promotion campaigns
should usually be contracted out to private sector specialists (see Piotrow et al. 1990).
1.  Social marketing.  AMR media and  point of  purchase promotion  can  increase
commercial retail  sales of temporary supply methods.  What happens to  sales levels after this
promotion has been withdrawn is yet to be seen.  Advertising may require regulatory reform as well
as donor subsidies; funds for  brand-name advertising should not be committed until and  unless
regulations permit advertising of ethical products (i.e., contraceptives). It does not appear likely that
commercial manufacturers and/or distributors will invest their own funds in mass media advertising,
although they may promote their contraceptive commodities thro!gh other channels such as detailers
and salesmen.
2.  Paynmnt or reimbursement  for services rendered by the private sector.  Voucher or
capitation systems have been proposed to reimburse clients treated by private providers.  However,
it is a complex option which would require
a total revamping of the financing and delivery of health care, although it may be an
initiative that could be tested or applied on a  limited basis for some services such as
family planning.  In tandem with such a switch, some assistance must be given to the
private sector both to gain access to the resources it needs to develop services, and to
promote insurance or  other coverage  . . . for  the population not covered  by  the
reimbursement system (Lewis and Kenney 1988, p.121).
6.2.2.  Promote  private  sector supply of family planning  goods and serices
Increasing the demand for private family planning goods and services will stimulate the
private sector to expand its capacity to attend that demand.  At the same time, donors can take steps
to directly increase private sector supply.
1.  Underwrite or  guarantee capital  investments in  private  sector
infrastructure
a.  Provide access to loan capital  for construction  of contraceptive  manufacturing
facilities.  Local production of contraceptives was recommended earlier, yet potential manufacturers
may lack sufficient start-up capital for construction or upgrading of facilities.  Care must be taken
to  ensure an adequate market for anticipated production.  For example, loans could be tied to
government and donor commitments to purchase locally produced products for  public and NGO
outlets.
b.  Provide grants or access to loan capital  for  construction  of clinical  facilities.
Constructing clinical facilities should be a  low priority,  especially if the aid recipient will have
trouble covering recurrent costs.  Approval of loans for construction of clinical facilities should
follow the usual market analyses required of any commercial undertaking, such as linkages to captive
populations (e.g., health insurance plans) or product diversification (adding family planning to an
existing facility rather than building a free-standing family planning clinic).
2.  Underwrite recurrent costs of providing family planning through
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a.  Price subsidies for  contraceptive  products.  Some areas may have well-developed
commercial retail networks, but prices of commercial contraceptives are beyond the reach of many
consumers.  Social marketing programs can provide subsidies to keep retail prices low enough to be
affordable to consumers while still guaranteeing an acceptable profit margin for  distributors and
retailers.
b.  Support to NGOs.  While donors usually explicitly refuse to cover recurrent costs
(other than commodities) in the public sector, recurrent cost support to NGOs is the rule rather than
the  exception.  This  paper  does  not advocate eliminating NGO  support,  but it  does  suggest
reexamining the bases for initiating and continuing both commodity and financial support.
NGOs are thought to have a competitive advantage in serving hard to reach populations
and in providing non-clinic-based family planning services.  Therefore, before initiating support to
an  NGO,  the donor  should ascertain that the  organization is,  in fact,  physically located in an
unserved area and  that it will provide methods previously unavailable to the target population.
Creating brand-new single-purpose  family planning  NGOs should be a very low priority.  Continuing
funding should be based on demonstrated impact and efficiency, not just total production or cost per
CYP, but geographic coverage or contribution to method and total prevalence. Management support
should be provided to improve organizational accountability to the user population and operational
efficiency.  Support  to  NGOs which  do  not contribute to  prevalence should be  phased out.
Successful NGOs should be expected to cover greater portions of their operating expenses through
local sources, including user fees, cross-subsidization, and/or local donors.
3.  Tax  breaks  for  employers  and  health  care  financiers  who
underwrite family planning
Tax breaks for financing family planning are attractive because they do not require any
cash outlay. Many countries already exempt charitable contributions or health care expenses. Firms
could be encouraged not only to provide family planning for employees and dependents, but also to
make cash and/or in-kind contributions to family planning NGOs.
4.  Sharing public sector facilities with the private sector
In many countries, public sector facilities stand vacant many hours of the day, especially
in the late afternoon, evenings, or weekends. Local directors should be encouraged to permit private
organizations, especially NGOs, to operate after-hours family planning  clinics and wherever feasible,
to charge for services rendered.
6.3.  Pilot studies and coordinated  evaluation  activities
Even  the  best-planned program will  present  unforeseen opportunities for  program
expansion.  Donors should reserve  funds to  be able to  respond to  these opportunities though
designing and implementing  self-contained, limited-scope  pilot projects.  The private sector will often
be best-suited for  these projects,  although decentralized public systems may allow local outlets
enough autonomy to undertake such ventures as well.
Process  evaluation should be  built  into every program  and  pilot project.  Impact
evaluation is often beyond the means of individual projects because of limitations on funding, staff,
or time.  Large-scale data collection efforts, such as national prevalence surveys,  should include46  Private  Sector  Approaches  to Effective  Fandly  Planning
enough  country-specific  information  to permit  impact  evaluation  of at least national-level  projects.
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